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Two municipal landfills and one public septic system in Southern Ontario were studied as 
potential sources of the pharmaceuticals ibuprofen, carbamazepine, gemfibrozil, caffeine, 
sulfamethoxazole, and naproxen to groundwater.  The background chemistry at each site was 
also determined.  Pharmaceutical analysis was conducted using isotope dilution techniques, 
coupled with solid phase extraction followed by high performance liquid chromatography 
electrospray tandem mass spectrometry (HPLC-ESI- MS/MS).  An assessment of method 
performance and extensive quality assurance and quality control practices were employed.  
At the septic system site, pharmaceuticals were detected at the furthest sampling point, 30 m 
downgradient from the source area.  The highest concentrations measured in groundwater 
were for carbamazepine (2,050 ng L-1), sulfamethoxazole (1,990 ng L-1) and ibuprofen (1,790 
ng L-1).   The other pharmaceuticals analysed were observed at concentrations in the range of 
<1 to 10 ng L-1 (gemfibrozil), <8 to 625 ng L-1 (naproxen), and <1 to 160 ng L-1 (caffeine).  
Under saturated groundwater transport, attenuation was not strong within the plume as all 
pharmaceuticals were detected at distance from the source.  In the unsaturated zone, most 
pharmaceuticals appeared to be more greatly attenuated than in the saturated zone.  This 
greater extent of removal in the unsaturated zone is attributed to increased degradation 
associated with elevated oxygen concentrations. At the two landfill sites, no pharmaceutical 
compounds were detected in any of the groundwater samples collected within previously 
defined plumes. Assuming these drugs are disposed in landfill wastes, the absence of 
detections suggests degradation and attenuation of these pharmaceuticals is occurring.  Some 
of the conditions that may contribute to attenuation include a thick unsaturated zone, strongly 
reducing conditions, and high sorptive capacity of the waste.  Specifically, waste typically 
 iv
has a higher organic content than aquifer materials, and a lower pH, particularly in the early 
stages of decomposition.  These conditions would result in a potentially higher attenuation of 
drugs within the waste pile.  This study suggests that management programs focused on 
protection of groundwater quality should take into consideration the potential persistence of 
pharmaceuticals in septic system environments.  
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1.0 Introduction 
1.1 Pharmaceuticals in the Environment 
Pharmaceutically active compounds (PhACs) are gaining increased attention in the literature 
and media alike.  There are a variety of reasons for this increased attention, including the 
unknown impact of PhACs to both human and ecosystem health, and the potential additive 
effects of PhAC exposure.  Whereas each pharmaceutical is typically found at a low 
concentration, the combination of multiple PhACs can result in environmentally significant 
concentrations.  With improved analytical methods capable of detecting PhACs in 
environmental samples, often with complex matrices, it is possible to study the fate and 
transport of PhACs at ever decreasing concentrations.  In this study, the pharmaceuticals of 
interest are carbamazepine, caffeine, ibuprofen, sulfamethoxazole, naproxen and gemfibrozil. 
 
Studies have documented the presence of many pharmaceutical compounds, including those 
of interest in this study, in sewage effluent, surface waters and groundwater.  Sources of 
PhACs to surface water and groundwater can include sewage effluent, runoff from 
agricultural applications, waste disposal sites, septic systems, and pharmaceutical production 
plants (Figure 1.1).  An extensive review of surface waters in the United States indicated that 
62 % of the rivers evaluated were observed to have at least one of the 22 pharmaceuticals 
measured (Cahill et al., 2004), with caffeine and triclosan being two of the most frequently 
detected (Kolpin et al., 2002).  Caffeine was detected in approximately 60% of the rivers 
sampled, with a maximum concentration of 6 μg L-1 (Kolpin et al., 2002).  Ibuprofen (1.0 μg 
L-1), gemfibrozil (0.79 μg L-1) and sulfamethoxazole (1.9 μg L-1) were also detected (Kolpin 
et al., 2002).  Extensive reviews of existing literature on the presence of pharmaceuticals in 
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the environment also have been completed ( Halling-Sørensen et al., 1998; Heberer, 2002; 
Nikolaou et al., 2007; Khetan and Collins, 2007), illustrating the number of studies on this 
subject and the increasing detection of PhACs in environmental samples.   
 
Sewage effluent has been identified as a major source of pharmaceuticals to surface water 
(Heberer, 2002; Vieno et al., 2006; Yu et al., 2006; Gros et al., 2007; Nikolaou et al., 2007).  
The pharmaceuticals that were a part of this study have been detected in surface waters as a 
result of sewage effluent.  Yu et al. (2006), found the presence of ibuprofen (250 ng L-1), 
naproxen (380 ng L-1) and gemfibrozil (130 ng L-1) in treated sewage effluent discharging to 
surface waters.  Vieno et al. (2006) observed sewage effluent with carbamazepine 
concentrations up to 470 ng L-1, with recipient surface waters having a maximum 
concentration of 66 ng L-1.  In one study, caffeine was detected at concentrations ranging 
from 13 to 107 ng L-1 downstream of a sewage treatment plant (Rabiet et al., 2006).  A 
survey in Spain investigating concentrations of river systems downstream of sewage 
treatment plants identified multiple drugs, including caffeine (305 ng L-1), ibuprofen (44 ng 
L-1), naproxen (9 ng L-1), gemfibrozil (2.3 ng L-1) and carbamazepine (56 ng L-1) (Pedrouzo 
et al., 2007).  Additional studies have identified agricultural runoff as a source of PhACs to 
surface waters (Lissemore et al., 2006).  More recently, attention has been directed towards 
the investigation of PhACs in groundwater, which is the focus of Chapters 2 and 3. 
 
1.2 Introduction to Study 
The six drugs included in this investigation, carbamazepine, sulfamethoxazole, caffeine, 
naproxen, gemfibrozil and ibuprofen, were selected based on their high prescription rates, 
 3
presence in other environmental settings, and in some cases, their observed persistence in the 
environment.  Carbamazepine, for example, is considered an environmentally relevant PhAC 
because it is fairly recalcitrant, and has been identified in previous literature as an indicator 
for urban influence on water systems primarily because it is consistently detected in surface 
water and groundwater, it is fairly conservative, but still capable of disrupting aquatic 
environments (Strauch et al., 2008).  The drugs selected for this study cover a wide range of 
properties such as solubility, medicinal use, acid-base dissociation constant (pKa), and 
octanol-water partitioning coefficient (Kow), which allows for a broad range of interpretation 
of transport properties in a variety of settings. 
 
The settings investigated include groundwater flow systems downgradient of two municipal 
landfills and one septic system.  The two municipal landfills are both engineered landfills, 
where one closed recently and is no longer accepting waste.  The second is still operating.  
Both sites are characterized as having a thick vadose zone above the water table, with well-
defined groundwater plumes containing organic and inorganic contaminants (Region of 
Waterloo, 2008; CH2MHILL, 2008).  The septic system discharges into a shallow aquifer, 
also with a well-defined plume.  The purpose of investigating these settings was to expand 
the existing literature on the occurrence and transport of PhACs in groundwater.  
 
1.3 Organization of Thesis 
This thesis has been organized into three chapters.  The first chapter provides a brief 
introduction to the presence of pharmaceuticals in the environment.  An introduction to the 
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pharmaceuticals that were studied, their presence in the environment, and the sites that were 
investigated are also provided. 
 
Chapter 2 presents the findings of the study conducted at the septic system site.  In this 
chapter, pharmaceutical concentrations observed in groundwater downgradient of the septic 
system are described.  Particular attention is given to quality assurance and quality control 
(QA/QC), and a detailed discussion of the factors affecting the fate and transport of 
pharmaceuticals in both the saturated and unsaturated zones is provided. 
 
Finally, Chapter 3 introduces the findings, both geochemical and pharmaceutical, at the two 
municipal landfills studied.  A discussion relating to the transport properties of the 
pharmaceuticals in relation to a landfill hydrogeological setting is provided, and QA/QC 





Figure 1.1 – Potential sources and transport pathways for pharmaceuticals in the 
environment.  Adapted from a figure originally developed by Heberer (2002). 
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2.0 Presence of Pharmaceuticals in a Septic System Groundwater Plume 
2.1 Introduction 
Septic systems are a common method for treating and releasing wastewater, particularly in 
rural settings in North America.  They are designed to treat the main contaminants of concern 
associated with septic beds: pathogens, organic carbon and ammonia (see Appendix A for 
details on septic system functioning).  Until recently, little emphasis was placed on other 
contaminants of concern, including pharmaceutically active compounds (PhACs) (Godfrey et 
al., 2007; Carrara et al., 2008).  Because many of these compounds are designed to have 
metabolic stability to function in the body, pharmaceuticals are often resistant to 
biodegradation and can therefore persist in the environment (Suntisukaseam et al., 2007).  In 
addition, because of the large volumes used, they have been classified as environmentally 
relevant compounds (Scheytt et al., 2006). 
 
The study of pharmaceuticals in groundwater has generally received less attention than 
pharmaceuticals in surface water, however, the number of studies focused on 
pharmaceuticals in groundwater has been increasing steadily.  Some of the identified sources 
to groundwater include bank infiltration (Massmann et al., 2008), artificial groundwater 
recharge (Drewes et al., 2002), agricultural infiltration (Heberer et al., 1998; Scheytt et al., 
2007; Siemens et al., 2008), landfills (Eckel et al., 1993; Schwarzbauer et al., 2002; Holm et 
al., 1995), and septic systems (Conn et al., 2006; Swartz et al., 2006; Godfrey et al., 2007; 
Carrara et al., 2008) (Figure 1.1). 
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2.1.2 Pharmaceuticals in Septic Systems 
Recently, septic system plumes containing PhACs have been investigated.  Swartz et al. 
(2006) studied the release of PhACs into a sand aquifer from a multi-resident property in the 
United States.  Concentrations within the tank were as high as 23,000 ng L-1 for caffeine, and 
65,000 ng L-1 for paraxanthine.  These compounds were also detected several meters 
downgradient from the source, with a maximum groundwater concentration observed for 
caffeine of 1,710 ng L-1.  Conn et al. (2006) collected samples from 30 onsite treatment 
systems, 22 of which were septic tank-based.  Analysis of tank samples indicated several 
pharmaceuticals in the 10’s of μg L-1 range.  A study conducted by Godfrey et al. (2007) 
found the presence of pharmaceuticals including carbamazepine and sulfamethoxazole at 
concentrations up to 450 ng L-1 in a shallow aquifer below a high school septic bed in 
Montana, USA.  The same study also detected pharmaceuticals in groundwater below an 
urban area containing multiple residential tile beds at concentrations less than 25 ng L-1, with 
the exception of caffeine that had a maximum concentration of 206 ng L-1.  More recently, 
Carrara et al. (2008) observed groundwater with elevated concentrations of several PhACs at 
two of three tile bed sites in Ontario, Canada.  An evaluation of groundwater downgradient 
of a tile bed in Long Point, Ontario detected the presence of nine pharmaceutical compounds 
having maximum concentrations in the range of 20 to 12,000 ng L-1.  Five pharmaceutical 
compounds were detected in a plume downgradient of a tile bed at Lake Joseph, whereas at 
the third site, Point Pelee, Ontario, only two pharmaceutical compounds were observed at 
one shallow sampling point in the plume.  While the number of studies is limited, it is 
apparent that septic systems are a source of pharmaceutical compounds to groundwater, and 
therefore potentially surface water and drinking water.  The mechanisms controlling the 
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release and transport of pharmaceuticals in groundwater, however, are unclear and require 
further attention.  
 
2.1.3 Pharmaceutical Disposal Patterns  
There are a variety of methods in which pharmaceuticals are introduced to septic effluent, 
including direct disposal of unused or expired medications with the household’s grey or 
black water.  Multiple surveys conducted in the U.K. determined that approximately 10% of 
households surveyed had disposed of their PhACs in this manner (Bound et al., 2006; Slack 
et al., 2007).  More importantly, however, pharmaceuticals may enter septic bed systems by 
excretion into wastewater either as a parent compound or as a metabolite (Ternes, 1998).  
The mass of excreted parent compound varies, depending on the structure of the drug, the 
mechanisms of the drug, the dosage or quantity, and the physiology of the individual (Bound 
and Voulvoulis, 2005).  Typically only a small percent of the ingested drug is excreted in the 
unchanged form (Khetan and Collins, 2007; Siemens et al., 2008).  The metabolized forms of 
the drugs which are excreted from the human body are often more reactive, more water 
soluble, and sometimes more toxic than the parent drug (Halling-Sørensen et al., 1998; 
Scheytt et al., 2007).  Once in the environment, these metabolites may be modified further, or 
may revert to the original parent compound (Bendz et al., 2005).  Predictions on the fate of 
PhACs in the environment require knowledge of usage rates, quantities excreted and/or 
disposed, transformation rates, and transport processes controlling both the parent compound 
and reaction products.  
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2.1.4 Purpose of Study  
Pharmaceuticals and their metabolites may be introduced into a septic system through a 
variety of mechanisms.  A number of studies have already identified that they can persist and 
enter into groundwater below and downgradient of tile beds (Conn et al., 2006; Swartz et al., 
2006; Godfrey et al., 2007; Carrara et al., 2008).  Because it is not uncommon for septic 
system plumes to eventually discharge to surface water bodies or near to drinking water 
supplies, it is important to understand where and how tile beds act as sources of PhACs as a 
way to ultimately understand the impact of such contaminants to groundwater, and 
consequently to human and aquatic health.  In addition, because PhACs are able to be 
detected at such trace levels, the potential exists for their application as highly sensitive 
tracers of wastewater contamination. 
 
2.2 Methods 
The septic system at Long Point Provincial Park in Ontario, Canada has been extensively 
studied over the past 16 years (Robertson, 2008).  The geology and chemistry of the site has 
been described previously (Aravena and Robertson, 1998; Robertson et al., 2000; Robertson, 
2008; Carrara et al., 2008).  The septic system at the site services a campground with 
approximately 200 overnight campsites, as well as patrons with day passes to the park.  The 
park operates seasonally from May to November, and therefore for part of the year there is 
no loading to the tile beds.  The single comfort station at the site is serviced by two tile beds, 
each approximately 290 m2.  The tile bed evaluated in this study has been used exclusively 
since 1990, with the exception of a two year period from 1995 - 1996 when the other tile bed 
was used.  The tile bed drains into an aquifer that is 5 - 6 m thick, silt free with fine to coarse 
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primarily calcareous sand, overlaying a clayey silt aquitard.  It has a hydraulic conductivity 
of 2 x 10-4 m s-1, fraction of organic carbon (foc) of 0.15% wt., and a groundwater velocity in 
the area influenced by the septic effluent during loading of approximately 40 m yr-1 
(Robertson, 2008).  The septic plume extends southward into the moderately homogeneous 
sand aquifer with a low dispersivity, therefore the plume retains a large core zone that is 
relatively unaffected by dilution (Robertson, 2008).  The plume eventually discharges into 
Lake Erie (Robertson, 2008).  
 
2.2.1 Field Methods 
Groundwater samples were collected on September 19, 2007 using a peristaltic pump 
connected to 0.64 cm (¼”) diameter dedicated polyethylene tubing.  The tubing sections were 
briefly purged, from 30 s to 1 minute, prior to collecting groundwater samples. The 
groundwater samples were filtered using 0.45 μm in-line Thermopor Membrane filters.  
Samples were collected for analysis of pharmaceuticals, anions, phosphate and ammonia.  
The pharmaceutical samples were collected in glass amber bottles in duplicate and acidified 
to a pH < 2 using 16N H2SO4.  One sample was maintained at 4oC and the other frozen until 
analysis.  Samples for PO4 and NH3/NH4-N analysis were collected in high density 
polyethylene (HDPE) bottles and acidified using 16N H2SO4.  Samples for anion analysis 
were also collected in HDPE bottles.  Two sets of field blanks were collected.  Blind 
duplicates were collected at four locations, or approximately one duplicate per 10 wells 
sampled. 
 
2.2.2 Reagents  
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Drug standards for carbamazepine, gemfibrozil, naproxen, sulfamethoxazole, ibuprofen and 
caffeine were obtained from Sigma Aldrich Canada.  For each analyte, a unique isotope-
labelled internal standard was used.  Table 2.1 outlines the unique internal standards used for 
each analyte, together with the properties of each analyte and internal standard.  All internal 
standards were obtained from CDN Isotopes (Quebec, Canada) with the exception of 
sulfamethoxazole d4 (Toronto Research Chemicals, Toronto, ON, Canada). 
 
Nanopure water (Milli-Q water) was provided through the use of a 0.45 μm Millipore Q-
Gard1 unit.  High performance liquid chromatography (HPLC) grade methanol (MeOH) 
(99.9%), ammonium acetate, formic acid, acetic acid and acetonitrile were obtained from 
Caledon Laboratories Ltd. (Georgetown, ON, Canada).  
 
All pharmaceutical stock solutions were prepared by measuring 10 mg of either an analyte or 
an internal standard and dissolving in MeOH/Milli-Q water (50:50 v/v), with the exception of 
gemfibrozil and its internal standard (gemfibrozil d6), which were dissolved in 10% 0.03M 
NaOH in MeOH/nanopure water (50:50 v/v), and internal standards for ibuprofen and 
naproxen, which were dissolved in pure MeOH.  The solvent selected was based on the 
solubility of each compound. 
 
2.2.3 Sample Preparation 
Samples stored at 4°C were allowed to reach room temperature.  Frozen samples were 
allowed to thaw to room temperature, and were vacuum filtered using 0.45 μm nylon filters 
to prevent clogging of the solid phase extraction (SPE) cartridges by a gel residue that 
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formed as a result of freezing.  A sorption study was conducted that evaluated the loss of the 
analytes onto the nylon filters.  The results indicated that there was minimal to no sorption of 
all pharmaceuticals to the nylon filters (Hebig, 2008) and therefore it is not expected that this 
step will have affected the aqueous concentrations of the PhACs of interest.  A laboratory 
blank was also prepared for each set of samples analysed. 
 
One hundred mL of each sample was spiked prior to SPE with a mixture containing all six 
internal standards to achieve a concentration of 1 μg L-1 of each internal standard after the 
SPE step.  Unique internal standards were utilized for each analyte to assess analyte losses 
during the SPE step and matrix suppression during analysis.  Utilizing a unique internal 
standard for each pharmaceutical provides the most accurate representation of the unknown 
analyte to correct for losses during SPE, instrument suppression and other errors during 
analysis (Gros et al., 2007).  
 
Solid phase extraction was performed using Oasis HLB 5 mL glass cartridges under 
approximately 13 cm (5 in.) Hg of vacuum.  These cartridges have been used previously for 
PhAC analysis in environmental applications (Hao et al., 2006; Vanderford and Snyder, 
2006; Feitosa-Felizzola et al., 2007; Gros et al., 2007; Díaz-Cruz et al., 2008).  Cartridges 
were conditioned with 3 mL of HPLC grade MeOH and equilibrated with 3 mL Milli-Q 
water.  The cartridges were loaded with the samples and washed using 3 mL of 5% MeOH 
(v/v).  Finally, the cartridges were eluted with three repeats of 2 mL of MeOH.  The eluate 
was collected in a glass amber bottle and stored at 4°C until time of analysis.  Use of SPE 
cartridges serves two purposes, 1) impurities are removed from the samples, minimizing 
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instrument contamination and interferences during analysis, and; 2) the samples are 
concentrated, which improves detection limits.  In this study, 100 mL of sample was 
concentrated to 6 mL, yielding a concentration factor of approximately 17.  A set of blind 
spiked laboratory samples were prepared with analyte concentrations of 0.1 μg L-1, 0.5 μg L-
1, and 1.0 μg L-1.  The purpose of these spiked samples was two-fold; 1) to evaluate the 
analysis and calibration of the MS/MS method, and 2) to evaluate the recovery of analytes 
and internal standards passing through the SPE cartridges.  
 
Samples that were frozen were prepared within 3 months, and all samples extracted in MeOH 
were analyzed within 6 months.  A cursory investigation of the impact of freezing samples 
and storing MeOH extracts on carbamazepine concentrations, presented in Appendix B, 
indicates that these processes did not affect the visual interpretation of carbamazepine 
plumes. 
 
2.2.4 Pharmaceutical Analytical Methods 
Analysis for pharmaceutical compounds was performed using HPLC electrospray tandem 
mass spectrometry (HPLC-ESI-MS/MS).  The HPLC was an Agilent 1100 series operated 
using an eluant gradient.  The mass spectrometer was an Applied Biosystems MDS SCIEX 
4000QTrap.  The nebulizer gas at the ionization source and the collision gas used to fragment 
the parent ion was N2.  A multiple reaction monitoring scan (MRM) was utilized for 
quantification, which occurred through a signal ratio between the analyte peak to that of the 
corresponding internal standard. 
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The analytical procedures utilized were modified from procedures described by Vanderford 
et al. (2003) and Stafiej et al. (2007).  Analyses of caffeine, carbamazepine and 
sulfamethoxazole were conducted in positive ESI mode.  A Symmetry RP18 column (Waters 
Corporation, Mississauga, ON, Canada) was used with a length of 50 mm, an internal 
diameter of 4.6 mm, and a particle size of 3 μm.  The flow through the column was 1.25 mL 
min-1, with an injection volume of 15 μL.  Mobile phase A consisted of 5 mM ammonium 
acetate and 0.1 % formic acid in nanopure water.  Mobile phase B was 100 % MeOH with 
0.1 % formic acid.  The gradient started at 15 % for mobile phase B, after 0.76 min increased 
to 100 %, then at 2.5 min decreased back to 15 % until 4 min was reached.  
 
Naproxen, gemfibrozil, and ibuprofen were analysed in negative ESI mode.  An XDB-C18 
column (Agilent Technologies, Mississauga, ON, Canada) with a length of 150 mm, an 
internal diameter of 4.6 mm and a particle size of 5 μm was used.  The flow rate through the 
column was 1 mL min-1, with a total injection volume of 10 μL.  Mobile phase A, at pH 4, 
was 30 % acetonitrile diluted with nanopure water with 6.9 mM acetic acid.  Mobile phase B 
was 100 % acetonitrile.  The gradient started at 0 % of mobile phase B, at 18 min increased 
to 3 %, at 22 min to 12 %, 40 min to 40 %, and ended at 45 min at 0 %. 
 
2.2.5 Calibration 
Instrument calibration was performed using an 8-point linear regression and a weighting 
factor of 1/x2, with a linear correlation coefficient of at least 0.999 (Table 2.2).  The 
accuracies of most calibration standards used were 100 +/- 5% (Table 2.2).  Accuracy is a 
measure of how close the calculated (measured) value was for each calibration standard, to 
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the expected concentration.  The method detection limit (MDL) and limit of quantification 
(LOQ) were determined using a signal-to-noise ratio with a standard deviation of 3, where a 
signal to noise ratio of 3 was used to calculate the MDL and 10 was used to calculate the 
LOQ.  Instrument detection limits are provided in Table 2.2, together with method detection 
limits that are corrected for the SPE concentration factor.  The concentrations were 
determined using the external calibration curve by comparing the measured responses for the 
internal standards added to each sample to that of each analyte.  
 
2.2.6 Geochemical Analytical Methods 
Determinations of ammonia concentrations were made using automated colorimetric 
procedures at an external laboratory.  Phosphate determinations were made 
spectrophotometrically with a HACH DR/2010 at 880 nm using the HACH ascorbic acid - 
molybdenum blue method.  Anion concentrations were performed using ion chromatography. 
 
2.3 Results and Discussion 
2.3.1 Geochemical Analysis 
Concentrations of major ions and nutrients were determined for all the piezometers sampled, 
and contour diagrams and depth profiles are presented in Figures 2.1 and 2.2, respectively.  
Tabulated results are provided in Appendix C.  A total of five samples were analysed in 
duplicate for all geochemical parameters, for a total of 26 duplicate analyses.  All duplicate 
analyses were similar to one another, with an average percent difference of 0.93% and a 
standard deviation of 1.1.  Additional information on the geochemistry of the groundwater at 
the site is available in previous studies (Robertson and Harman, 1999; Robertson et al., 2000; 
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Robertson, 2008; Carrara et al., 2008).  Concentrations of PO4-P (up to 8.1 mg L-1), NO3-N 
(up to 98.25 mg L-1) and Cl (up to 62.8 mg L-1) were observed to be highest beneath and 
adjacent to the tile bed, decreasing further downgradient from the source.  The Cl plume 
extends across the entire length (30 m) and depth (6 m below grade) of the cross section 
evaluated, maintaining a plume core across the distance of flow.  Concentrations of Cl at the 
site decreased with distance from the source, however, the decrease in concentration of this 
conservative tracer was minimal, indicating that dispersive attenuation does not play a key 
role in this aquifer across the distance studied.  This observation supports the findings of 
Robertson (2008), who observed a large core zone relatively unaffected by dilution, 
suggesting that the aquifer has a relatively low dispersivity. 
 
Concentrations of NH3/NH4-N were below the detection limit (<0.01 mg L-1) at the majority 
of piezometers sampled, particularly those that were deeper and/or further downgradient 
from the tile bed.  These observations are similar to findings by Böhlke et al. (2006) who 
found that ammonium plumes tend to be small relative to those of other constituents, with 
highest concentrations observed closest to the source.  The maximum NH3/NH4-N 
concentration detected was 11.6 mg L-1 in the piezometer nest at the edge of the tile bed.  The 
concentrations of N species at Long Point are similar to those observed at another tile bed 
located in a similar geological setting (Ptacek, 1998).  The behaviour of N species is closely 
related to the design of the septic bed (Appendix A).  Ammonium is thermodynamically 
unstable in the oxidizing conditions present in the unsaturated zone.  Therefore, within the 
unsaturated zone, NH4 is oxidized to NO3, which explains the presence of NO3 in the plume, 
and the general absence of NH3/NH4-N.  Ammonium also tends to exchange onto clay and 
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other mineral surfaces, leading to moderate attenuation relative to the average groundwater 
velocity (Böhlke et al., 2006; Repert et al., 2006), which could also contribute to the limited 
concentrations and travel distances relative to the conservative tracer Cl.  A previous study 
conducted by Robertson (2008) identified that at the Long Point site, NH4 was well oxidized 
and had limited presence in the piezometers closest to the tile bed, which our findings 
support.  At depth and distance, NO3 concentrations decline, likely as a result of removal 
through denitrification reactions, consistent with previous observations of denitrification in 
the Long Point aquifer (Aravena and Robertson, 1998). 
 
Concentrations of SO4 within the plume were variable.  The highest concentrations were 
observed directly below the tile bed (84 mg L-1), as well as at greater depths below the water 
table.  Concentrations for Mn were fairly consistent throughout the entire plume, with highest 
concentrations observed closest to and directly below the tile bed.  Elevated concentrations of 
Mn are attributed to release from mineral surfaces through reductive dissolution reactions as 
observed at other septic system sites (Ptacek, 1998). 
 
The transport of PO4 at the site has been well described by Robertson (2008).  Elevated PO4 
concentrations were observed to be limited to shallow depths, with attenuation occurring 
away from the source zone (Figures 2.1, 2.2).  Transport of PO4 can be limited by 
adsorption/desorption and precipitation/dissolution reactions (Ptacek, 1998).  Because PO4 is 
negatively charged, positively charged mineral surfaces promote adsorption reactions.  A 
sediment analysis by Robertson (2008) determined that the aquifer contains acid-extractable 
 18
Al, Fe, and Mn minerals, which could indicate that the presence of hydroxide minerals plays 
an important role in adsorption of PO4. 
 
2.3.2 Pharmaceutical Analysis 
2.3.2.1 Quality Control and Quality Assurance 
Pharmaceutical analyses were conducted along the cross section for caffeine, carbamazepine, 
sulfamethoxazole, gemfibrozil, naproxen and ibuprofen.  Concentrations of all drugs 
analysed were consistently below detection in laboratory and field Milli-Q blanks prepared 
using the same SPE process employed for the unknown samples (Table 2.3), with the 
possible exception of caffeine at concentrations less than 1 ng L-1, suggesting contamination 
within the instrument.  However, because the background peak for caffeine was present in all 
samples, including the calibration standards, no correction beyond those obtained through the 
application of the calibration regression equation was required.  Blank MeOH/Milli-Q 
samples spiked with internal standards for direct injection into the HPLC were below 
detection limits (Table 2.3) of all the target analytes, indicating there is no potential for 
contamination from the addition of the internal standards used. 
 
Blind Milli-Q spiked samples prepared for quality control measures had high accuracies (91-
110 %) for all drugs across a range of concentrations (100 to 1000 ng L-1) (Table 2.3), 
indicating the accuracy of the calibration and analysis methods.  The accuracy is calculated 




2.3.2.2 Absolute Method Recovery 
The absolute method recovery of the internal standards was expressed by comparing the peak 
area (counts) of the internal standard in a control set of Milli-Q spiked samples (method 
standards) passed through the SPE cartridges (n = 4) to MeOH/Milli-Q calibration standards 




(%)RecoveryMethodISAbsolute ×=  (2.1) 
In all unknown samples as well as the method standards, the internal standards were added 
prior to SPE, therefore the absolute method recovery is representative of the recovery of the 
SPE process, as well as the instrument detection capabilities.  The method standards were 
prepared to have final analyte concentrations of 0.2, 0.5, 1.0, and 5.0 μg L-1.  The effect of 
passing samples through a nylon filter is expected to be negligible for all of the drugs, based 
on a sorption study which indicated little to no loss of the PhACs from the aqueous phase 
when in continued contact with the nylon filters (Hebig, 2008).   
 
In addition, the absolute analyte recovery was calculated (Equation 2.2) for the method 
standards using the same method of comparing peak area in the method standards to peak 




(%)RecoveryMethodAnalyteAbsolute ×=  (2.2) 
The relative recovery of the analyte to internal standard was also calculated through 
Equations 2.3 and 2.4 to indicate the relation between internal standard recovery and 
calculated analyte concentration.  The relative recovery ratio (Equation 2.3) was calculated 
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for both the method standards and the calibration standards and then used to calculate the 









(%)RecoveryMethodRelative ×=  (2.4) 
The relative recovery is more reflective of the accuracy of the calibration and method, as it 
considers not only the internal standard recovery, but also the analyte recovery and therefore 
accounts for the internal standards that were used to calculate the final concentration of 
analytes in all samples. 
 
Table 2.4 and Figure 2.3 illustrate the three parameters calculated for the absolute method 
recovery of the method standards.  It is noted that ibuprofen (99 %), naproxen (86 %) and 
carbamazepine (86 %) had the best absolute recoveries of internal standards, however, the 
precision for all drugs ranged between 6 and 16 %.  The internal standard absolute recovery 
for sulfamethoxazole was very high (140 %), however, the absolute recovery of the 
sulfamethoxazole analyte was also high (151 %), which resulted in a satisfactory overall 
relative recovery of 107 % (Table 2.4, Figure 2.3), illustrating the importance of utilizing an 
appropriate internal standard for each analyte.  
 
For most of the pharmaceuticals studied, the absolute recovery of the internal standard in the 
method standards was similar to the absolute recovery of the corresponding analyte, which 
resulted in an acceptable relative recovery.  Carbamazepine, sulfamethoxazole, caffeine, and 
ibuprofen all had relative recoveries in the range of 99 to 107 %.  Naproxen and gemfibrozil 
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had higher relative recoveries (119 % and 122 % respectively), which indicates that 
measured values for these drugs could be elevated by approximately 20 % (Figure 2.3). 
 
2.3.2.3 Internal Standard Recovery 
Another recovery evaluation calculated considered the matrix effects of each individual 
sample, combined with the absolute method recovery.  In this recovery, the peak area of the 
internal standard in all unknown samples was compared to the peak area of the internal 
standard in the calibration standards that were analysed together within a single group of 




(%)RecoveryIS ×=  (2.5) 
For drugs analysed in positive mode, carbamazepine had the lowest average recovery (69 %), 
with a relative standard deviation (%RSD), or precision, of 13 %, and sulfamethoxazole had 
the highest recovery (96 %) and also the highest %RSD (20 %) (Table 2.5).  For the drugs 
analyzed in negative mode, average sample recoveries were between 84 and 97 %, but 
%RSDs were lower for all drugs (7-11%) (Table 2.5).   
 
It is not unusual for environmental samples to have a high standard deviation in the recovery, 
because each sample has a unique matrix that will affect the recovery of the analytes on the 
SPE adsorbant, as well as the electrospray efficiency.  Other studies investigating recoveries 
of drugs in environmental samples observed poor recoveries and high standard deviations for 
drugs (Hao et al., 2006; Pedrouzo et al., 2007).  For blind spiked Milli-Q samples, recovery 
of internal standards for positive drugs were <80 %, however, high relative recoveries (97 – 
107 %) indicate that the low internal standard recovery was compensated for in the final 
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calculation of the analyte concentration due to the addition of unique internal standards for 
each analyte.  The relatively low or inconsistent recoveries of the internal standards in the 
samples (both environmental and blind spiked Milli-Q) could also be the result of peak 
distortion that typically occurs when the eluate that is injected into the HPLC is a stronger 
solvent than the mobile phase, or simply the result of variations in the operation of the 
instrument. 
 
The relative recoveries of the blind Milli-Q spiked samples (99 - 109 %) (Table 2.5) indicate 
that the low recoveries of the internal standards were corrected through the use of isotope 
dilution techniques, given that the internal standard recoveries were similar to the unknown 
sample internal standard recoveries.  Using a unique internal standard for each PhAC with 
similar recovery behaviour helps to correct for different recovery of each compound. 
 
2.3.2.4 Pharmaceutical Findings 
All six drugs analysed in this study were detected within the groundwater plume.  The plume 
and depth profiles for each drug are presented in Figures 2.4 and 2.5, respectively.  Plume 
and septic tank concentration are presented in Table 2.6.  Carbamazepine and ibuprofen 
exhibited the overall highest concentrations and the furthest extent vertically and 
horizontally.  Sulfamethoxazole and naproxen both had similar trends in that their highest 
concentrations occurred in the sampling points below the tile bed, and then decreased fairly 
abruptly downgradient.  Concentrations of gemfibrozil were very low throughout the entire 
plume (10 ng L-1 to below detection limit (<1 ng L-1)).  The highest concentrations measured 
in groundwater were carbamazepine (2,050 ng L-1), sulfamethoxazole (1,990 ng L-1) and 
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ibuprofen (1,790 ng L-1).  In the septic tank, the highest concentrations were observed for 
ibuprofen (29,350 ng L-1) and caffeine (7,530 ng L-1).  The sample collected from the tank 
was not filtered in the field, and was only filtered during sample preparation, after being 
frozen.  This method could account for the lower carbamazepine concentration of 77 ng L-1 
in the tank relative to those observed within the groundwater plume (up to 2,050 ng L-1).  
Alternatively, the plume may reflect previous conditions when tank concentrations of 
carbamazepine were higher, as the tank input is not considered constant at this site due to its 
seasonal operation and the varying population that it serves.  
 
2.3.2.5 Partitioning, Sorption and Retardation Theory 
The pharmaceutical compounds studied range from neutral compounds, to those that 
completely dissociate, and to those that are partially dissociated over the pH range of the 
field site (6.7 to 7.2 (Carrara et al., 2008)).  The degree of compound dissociation is 
important when investigating the fate and transport of organic compounds, particularly when 
considering the degree of partitioning between solid and aqueous phases by sorption.  The 
degree of sorption is affected by the pH of the system and the acid-base dissociation constant 
(pKa) of each PhAC, and can be explained through parameters such as the octanol-water 
partitioning coefficient (Kow), which is often used to estimate partitioning coefficients (Kd).  
When pH > pKa, the PhACs in this study are dissociated into their anionic forms (Figure 2.6).  
This dissociation will influence the extent of sorption, as negatively charged compounds do 
not sorb as readily to soil particles and organic carbon (Haderlein and Schwarzenbach, 1993; 
Broholm et al., 2001).  This relationship does not hold true for sorption to minerals, such as 
iron oxides, that are neutral or weakly positive at typical groundwater pH and therefore can 
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more readily sorb anionic organic compounds (Appelo and Postma, 2006).  The influence of 
pH on Kd has been evaluated previously and it has been determined that for nonpolar 
compounds that are ionizable, pH influences the measured distribution of the compound 
between sorbed and aqueous phases (Haderlein and Schwarzenbach, 1993). 
 
Knowledge of the aquifer properties at the field site is important in understanding the degree 
of electrostatic attraction that may exist between the neutral or dissociated PhACs, and the 
soil particles.  Robertson (2008) performed sediment core analysis of the Long Point aquifer 
and determined that the aquifer sands are primarily calcareous, but also contain substantial 
amounts of acid-extractable Al, Fe, and Mn, which could indicate the presence of hydroxide 
minerals that may play an important role is sorption of negatively charged species.  In 
addition, the amount of organic carbon present is 0.15 wt % (Aravena and Robertson, 1998). 
 
2.3.2.5.1 Log Dow 
To express the relationship among Kow, pH and pKa, the log Dow, which is a pH dependent 
partitioning coefficient, was calculated from pH 0 to 14 using the following equation (Figure 








The pH range of relevance is that which exists at the site.  Because the temporal and spatical 
variation in pH at the site is not large, the range of pH values considered is 6.7 to 7.2, as 
determined by Carrara et al. (2008).  For some pharmaceuticals, particularly the acidic drugs 
that are dissociated under the pH conditions at the site, the log Dow varies substantially from 
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By employing knowledge of the pH dependant partitioning coefficient, along with the site-
specific aquifer properties, the retardation coefficient (R) was calculated for each PhAC for 
the pH range 0-14, and for the pH range at the site as obtained from Carrara et al. (2008) 




R ρ+= 1  (2.7)
where ρb is the aquifer bulk density, R is the retardation coefficient, and n is the effective 
porosity.  As in Robertson (2008) an assumed bulk density of 2.65 g cm-3 and an effective 
porosity of 0.35 were used.  The partitioning coefficient (Kd) was estimated using the 
following series of equations: 
663.0log679.0log += owoc KK  (2.8)
as developed by Gerstl (1990) and recently employed by Löffler et al. (2005) in a similar 
pharmaceutical application.  Koc is the octanol-carbon partitioning coefficient, and Kow is the 
octanol-water partitioning coefficient.  In place of log Kow, the log Dow is employed, allowing 
retardation to be calculated dependent on the pH of the system.  Finally, Kd is estimated 
based on the generalized expression: 
ococd fKK =  (2.9)
where foc is the fraction of organic carbon in the aquifer (0.15%, Aravena and Robertson, 
1998).  Depending on the equation selected to calculate the log Koc, the actual value 
determined for R for each pharmaceutical varied slightly, however, the relative trends 
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remained the same, and it is therefore useful for qualitative comparison of relative transport 
distances.  An examination of Figure 2.7 illustrates that R for all pharmaceuticals ranged 
from 1 to 6 over the pH range at the site, where ibuprofen carbamazepine and gemfibrozil 
had higher retardation coefficients than caffeine, naproxen and sulfamethoxazole. 
 
2.3.2.6 Saturated Zone Transport 
The septic plume extends southward into a moderately homogeneous sand aquifer 
(Robertson, 2008).  Based on the measured Cl concentrations, dispersive dilution is not 
considered a significant process and therefore Cl can be assumed to behave conservatively.  
The conservative nature of Cl is important in evaluating the transport of the pharmaceutical 
compounds and noting the decrease in concentrations relative to that of Cl.  This comparison 
provides an indication of which PhACs are attenuated by dispersive dilution only, and those 
that are more greatly attenuated are likely being affected by other processes, such as sorption 
or biodegradation.  The concentrations of PhACs in groundwater are a direct reflection of the 
concentrations in the septic tank.  Given the seasonal operation of the tile beds, combined 
with the varying population that the tank services, it is not likely a constant source for all the 
PhACs in this study.  Not having a constant source concentration makes interpreting all 
plume delineations challenging, as trends observed within each plume could be either the 
result of attenuation processes, or simply reflect temporal variations in input concentrations.  
For the purpose of this analysis, it will be assumed that the tank concentrations were 
relatively constant to aid in the interpretation of the attenuation of each PhAC. 
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A visual comparison of the ibuprofen and carbamazepine concentrations to Cl indicates that 
these two drugs behave relatively conservatively in the saturated zone, which is consistent 
with previous studies in which carbamazepine was persistent in groundwater settings (Hua et 
al., 2003; Kreuzinger et al., 2004), as well as ibuprofen (Scheytt et al., 2005; Carrara et al., 
2008).  Concentrations observed at the site for carbamazepine were substantially higher than 
observed in previous studies investigating septic effluent in groundwater, as well as surface 
water and sewage effluent concentrations (Lissemore et al., 2006; Yu et al., 2006; Benotti 
and Brownawell, 2007; Godfrey et al., 2007; Gros et al., 2007).  In this study, maximum 
groundwater concentrations for carbamazepine were in the range of thousands of ng L-1.  In 
the previous studies, observed concentrations were up to 16.2 ng L-1 (Lissemore et al., 2006) 
and 98.9 ng L-1(Yu et al., 2006) in surface waters receiving urban inputs, 65 ng L-1 in sewage 
effluent (Benotti and Brownawell, 2007), and between 60 – 210 ng L-1 in groundwater 
(Godfrey et al., 2007).   
 
Carbamazepine is a basic compound, characterized by a high pKa (Figure 2.6; Table 2.1), 
indicating that it is not dissociated over the pH range at the site.  It is moderately 
hydrophobic (log Kow=2.45).  Hydrophobic sorption is therefore expected to be an important 
sorption mechanism for this compound (Scheytt et al., 2005).  However, a previous 
laboratory study investigating sorption of carbamazepine onto Long Point sand found that 
given the nature of the sand (foc = 0.15%; Robertson, 2008), carbamazepine had a preference 
for the aqueous phase, and therefore sorption was minimal and the drug behaved nearly 
conservatively (Seibert, 2007). 
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Concentrations of ibuprofen in groundwater at the Long Point site (up to 1,790 ng L-1) were 
at least one order of magnitude higher than reported previously in surface water ( 150 ng L-1) 
(Gros et al., 2007), and were more similar to concentrations observed for sewage effluent 
(870 – 85,000 ng L-1) (Heberer, 2002), possibly due to photolytic degradation in surface 
water environments.  In contrast to carbamazepine, ibuprofen has a low pKa (Figure 2.6) and 
is therefore present at the site in a predominantly dissociated form, which indicates that in 
addition to hydrophobic sorption, other processes may influence the transport of ibuprofen as 
a result of its anionic form.  Based on its log Kow partitioning coefficient (3.97) and the 
relatively high calculated retardation factor, one would expect that ibuprofen would undergo 
a moderate to high degree of sorption, and would be greatly attenuated, however, this is not 
what was observed.  In a laboratory sand column study conducted by Scheytt et al. (2005), it 
also was determined that ibuprofen had a much higher mobility than would be expected 
based solely on the octanol-water partitioning coefficient.  These findings may be explained 
by Siemens et al. (2008), who identified that for acidic pharmaceuticals dissociated into their 
anionic form, sorption to negatively charged particles, such as the organic fraction of sand, is 
impeded by repulsive electrostatic forces.  This finding is supported by the log Dow values 
calculated for ibuprofen of 2.17 to 1.68 across a pH range 6.7 to 7.2 (Figure 2.7), which are 
significantly lower than the log Kow value of 3.97 for the pH range present at the field site, 
and therefore suggests a lower sorption potential.  The slightly lower mobility of ibuprofen 
relative to that observed for carbamazepine in this field setting may be the result of sorption 
of the negatively charged drug to positively charged sediment surfaces.  Alternatively, it 
could be the result of temporal changes in tank concentrations for these two PhACs. 
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Gemfibrozil was not observed at elevated concentrations at any location sampled (Figures 
2.4, 2.5).  The concentrations observed for gemfibrozil in groundwater in this study (1 – 10 
ng L-1) were generally lower than concentrations reported for treated sewage effluent (up to 
2,500 ng L-1) (Gros et al., 2007), surface waters (10-130 ng L-1) (Yu et al., 2006; Gros et al., 
2007), and groundwater (2 – 1960 ng L-1) (Carrara et al., 2008).  Like ibuprofen, gemfibrozil 
is an acidic compound with a moderate to high log Kow (4.77) (Table 2.1), and therefore 
transport of gemfibrozil is expected to be similar to ibuprofen.  Concentrations for 
gemfibrozil were low throughout the entire plume, and it did not appear to attenuate greatly 
along the distance investigated, assuming a relatively constant input concentration.  Like 
ibuprofen, over the pH range for the site, gemfibrozil is present in its anionic form, 
suggesting a lower sorption potential than would be expected if only the log Kow was 
considered.  At some of the sampling locations downgradient of the tile bed, concentrations 
were higher than concentrations closer to the source, which are similar to findings of 
Siemens et al. (2008).  Bendz et al. (2005) also observed a similar increase in concentrations 
of gemfibrozil along a river flow path, and attributed the increase to reversion of excreted 
metabolites back to the parent compound.  In human urine, gemfibrozil is excreted as 
approximately 70% metabolites, and only 6% unchanged as the parent compound (Siemens 
et al., 2008).  This study did not involve analysis of metabolites.  Alternatively, the higher 
concentrations may reflect temporal variations in discharge rates or complex geochemical 
conditions. 
 
Sulfamethoxazole concentrations in this study (average of 225 ng L-1, up to 1,990 ng L-1) 
were slightly higher than other groundwater findings for septic effluent plumes (10 – 450 ng 
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L-1) (Godfrey et al., 2007), but were within the same order of magnitude as observed in a 
previous investigation of groundwater (Godfrey et al., 2007).  An overview study indicated 
that sulfamethoxazole has been observed in a variety of groundwater settings in 
concentrations ranging from trace, up to 450 ng L-1 (Heberer, 2002), indicating that this drug 
is persistent in a variety of groundwater settings.  Sulfamethoxazole is an acidic compound 
characterized by a low log Kow (0.89), which results in a lower log Dow (0.59 to -7.11 over 
the pH range of 6 to 14) (Figure 2.7).  As a result, it would be expected that 
sulfamethoxazole would have a high mobility.  The calculated retardation factor also 
indicates a high mobility.  In this study, sulfamethoxazole concentrations were observed to 
decrease fairly abruptly downgradient from the source area.  This observation is consistent 
with field and laboratory studies conducted previously, which determined that sulfonamides 
actually have a high degree of initial sorption (Stoob et al., 2007; Wehrhan et al., 2007).  
Sulfonamides have two ionizable functional groups that affect transport in the environment, 
however, only the neutral and anionic forms are significant in the pH range at the Long Point 
site (Tappe et al., 2008).  It was found that uptake by cells for biodegradation is substantially 
higher for neutral species than charged (Tappe et al., 2008).  Sulfamethoxazole is neutral in 
its undissociated form, but given the pKa (Figure 2.6), very little of the drug would exist in 
the undissociated form, therefore it is unlikely that biodegradation plays a key role in the 
saturated zone for attenuation of sulfamethoxazole. 
 
Naproxen and caffeine appear to be the most highly attenuated of the drugs analyzed, if 
constant tank concentrations are assumed.  Concentrations of naproxen were substantially 
lower than observed in previous studies investigating septic effluent in groundwater, surface 
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water and sewage effluent (Lissemore et al., 2006; Yu et al., 2006; Benotti and Brownawell, 
2007; Godfrey et al., 2007; Gros et al., 2007).  In this study, maximum concentrations for 
naproxen were in the range of hundreds of ng L-1.  In previous studies, concentrations were in 
the range of 41.7 ng L-1 (Lissemore et al., 2006) in surface waters, and 380 ng L-1 in sewage 
effluent (Yu et al., 2006).  Based on its pKa (Table 2.1, Figure 2.6), naproxen is nearly 
completely dissociated into ionic components, resulting in a lower log Dow across the pH 
range at the site (Figure 2.7).  While the ionic form of naproxen would not be 
electrostatically attracted to the predominantly negatively charged soil and organic matter 
particles in the Long Point aquifer, there is potential for sorption onto iron oxides present in 
the aquifer material (Roberston, 2008).  It is likely that other processes are responsible for the 
high degree of attenuation given that the calculated retardation coefficient (Figure 2.7) for 
this PhAC is so low.  A possible explanation is that biodegradation may be playing a key role 
in the attenuation process of naproxen.  Tappe et al. (2008) proposed that drugs that are not 
sorbed to soil particles and remain in the aqueous phase are generally more biologically 
available, and potentially more prone to degradation reactions.   
 
Concentrations for caffeine were notably lower than previously reported concentrations for 
septic tank effluent, municipal sewage effluent, groundwater, and surface waters (Swartz et 
al., 2006; Conn et al., 2006; Benotti and Brownawell, 2007).  Concentrations of caffeine 
observed in this study were also markedly lower than a previous groundwater study that 
observed caffeine in a shallow monitoring well below an urban subdivision contaminated 
with domestic waste water, with concentrations up to 230 ng L-1 (Seiler et al., 1999).  This 
study by Seiler et al. (1999) determined that from a variety of wells sampled, the deeper 
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wells and wells further from the source did not have measurable concentrations of caffeine, 
even though some were contaminated by wastewater, as indicated by elevated NO3 
concentrations.  The findings at Long Point also indicate that in groundwater, caffeine is 
more readily attenuated than some of the other pharmaceuticals evaluated, assuming a 
constant source concentration.  The pKa (10.4) and calculated R value (1) suggest that 
caffeine would not be dissociated in this environment, and hydrophobic sorption would be 
minimal.  As a result, the observed losses may be due to biodegradation reactions.  
Bioavailability and uptake by cells is dependant on the ionic charge, where uptake by cells is 
much greater for neutral species than charged (Tappe et al., 2008), and therefore uptake of 
the neutral parent compound of caffeine may be a significant process in this system.  
 
To summarize, in the saturated zone all drugs showed at least some degree of attenuation 
when comparing groundwater concentrations to Cl concentrations and using the assumption 
that tank concentrations for these PhACs are relatively constant.  Dispersive dilution is a 
relatively insignificant process in the aquifer across the distance studied, and therefore, other 
processes such as hydrophobic or electrostatic sorption, and chemical degradation and 
biodegradation reactions would contribute to the attenuation of the non-conservative drugs.  
As attenuation was difficult to predict by examining properties such as the pKa, log Dow and 
R, other processes such as ion exchange, more complex adsorption reactions and degradation 
reactions may be important in determining fate and transport interpretation.  In addition, 
variability in PhAC concentrations throughout each plume could be the result of temporal 
changes in input (septic tank) concentrations.  Further studies such as column investigations 
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and additional sampling to obtain temporal tank concentrations would assist in delineating 
specific processes that affect transport of PhACs in this aquifer system.  
 
2.3.2.7 Unsaturated Zone Transport 
While the focus of this study was not on the unsaturated zone, the drugs leaching from the 
septic tank passed through the unsaturated zone prior to entering the groundwater system, 
which affected their fate and transport.  Studies pertaining to unsaturated, aerobic conditions 
indicate that, in general, pharmaceuticals show higher elimination and lower mobility under 
unsaturated conditions than during saturated transport (Scheytt et al., 2006).  The Long Point 
site is characterized by a shallow water table, which did not allow full removal prior to the 
wastewater recharging the water table, however, the decline in concentrations of the 
pharmaceuticals between the tank and the first sampling point (Table 2.6), clearly indicates 
that many drugs exhibit a much larger decrease in concentration across the unsaturated zone 
than the conservative tracer (Cl), indicating that degradation and/or sorption processes are 
playing a large role in the fate and transport of these PhACs in the unsaturated zone.  This 
analysis is based on the assumption that the tank concentrations are constant.  Based on the 
presence of NO3 in the plume, it is apparent that the NH4 in the septic tank is oxidized as it 
passes through the unsaturated zone, suggesting oxygen is present and therefore available for 
biodegradation and or oxidation reactions in the unsaturated zone. 
 
Another important consideration in the attenuation of all pharmaceuticals passing through the 
unsaturated zone is the pH of the system.  In many septic systems, including the tile bed at 
Long Point (Carrara et al., 2008), the pH is lowest in the groundwater closest to the tile beds 
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(Zanini et al., 1998).  The low pH is the result of the nitrification reaction that occurs in the 
unsaturated zone, which yields two moles H+ for every one mole of NH4+ oxidized into NO3-: 
+−+ ++→+ HOHNOONH 22 2324  (2.10) 
It can be assumed that the pH in pore water in the unsaturated zone is even lower than in the 
groundwater zone, which may have implications on the transport of pharmaceuticals in the 
vadose zone, because as calculated previously (Figure 2.7), retardation is shown to increase 
with decreasing pH.  Therefore, in addition to biodegradation in the aerobic unsaturated zone, 
processes controlled by the pH, including enhancement of hydrophobic sorption processes 
due to less extensive dissociation, and for those drugs that dissociate at low pH, electrostatic 
sorption of anionic pharmaceuticals onto cationic surfaces in the aquifer, may play a key role 
in their attenuation. 
 
The tank sample was not filtered in the field, and therefore it is also possible that the 
concentrations obtained are not entirely indicative of the aqueous concentrations.  For 
example, when the samples were acidified and the pH of the water was modified, this could 
have either increased sorption to colloidal matter, or caused desorption due to changes in 
partitioning preferences.  For the purpose of this interpretation, it is assumed that the 
concentrations obtained are representative of actual, constant aqueous concentrations in the 
tank.  It is, however, recognized that tank concentrations may not be constant as a result of a 
varying population which the septic system serves. 
 
Under anaerobic conditions, such as those that would be present in the tank, the biological 
transformation of most PhACs is hindered (Siemens et al., 2008), which could explain why 
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for many drugs, the concentrations were higher in the tank than those measured in the 
aquifer.  Ibuprofen, naproxen and caffeine were the PhACs that had the highest 
concentrations in the tank (Table 2.6).  All were orders of magnitude higher than 
concentrations found in groundwater, indicating extensive removal of these PhACs within 
the unsaturated zone.  Naproxen is excreted in urine as 10% of the parent compound 
(Siemens et al., 2008), which explains the high tank concentration.  Of all the PhACs studied, 
caffeine had the highest solubility, and also the second highest concentration in the tank, 
which is not surprising given the high consumption of caffeine in beverages (Table 2.1). 
 
Previous laboratory studies performed using unsaturated, aerobic sand columns determined 
that ibuprofen had a retardation factor of 3.0 (assuming linear sorption), and a high degree of 
attenuation during transport that could partly be attributed to biodegradation (Scheytt et al., 
2006).  Column studies conducted by Scheytt et al. (2007) indicated that ibuprofen is 
significantly retarded and transformed during passage through the unsaturated zone.  In the 
field, the concentrations of ibuprofen decreased markedly between the tank and the shallow 
groundwater (Table 2.6), indicating a high degree of removal in the unsaturated zone, which 
is consistent with the laboratory studies by Scheytt et al. (2007).   
 
Concentrations of sulfamethoxazole also decreased between the tank and the water table, 
however, the decrease was substantially less than that documented by Godfrey et al. (2007), 
who observed a decrease in concentrations of 15-1,200 times during passage through a 2 m 
thick, sandy unsaturated zone.  This difference could be the result of the tank concentration 
for sulfamethoxazole not being entirely representative as a result of not being filtered prior to 
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sample preservation, or to less effective removal processes in the unsaturated zone.  The 
difference could also indicate that tank concentrations for sulfamethoxazole are not constant. 
 
The concentrations of carbamazepine in the tank are lower than in the groundwater, 
preventing an estimate of removal rates.  The higher concentrations in groundwater may be 
indicative of variations in the tank concentrations.  However, previous laboratory scale 
studies under unsaturated conditions in sand found that carbamazepine showed minimal 
degradation and sorption, and that the unsaturated zone shows less elimination than saturated 
transport (Scheytt et al., 2006).  Riverbank filtration studies also showed that carbamazepine 
attenuation was minimal (Osenbruck et al., 2007).  Drewes et al. (2002) found that 
antiepileptic drugs persist during groundwater recharge.  The low pH in the unsaturated zone 
below the tile zones would not support sorption of this neutral compound.  Therefore, it is 
likely that minimal attenuation would have occurred in the unsaturated zone in this aquifer, 
particularly given the limited thickness of the vadose zone. 
 
2.3.2.8 Significance of Findings 
Because it is not uncommon for plumes from septic systems to eventually discharge to 
surface water bodies or to be captured by nearby drinking water supplies, it is important to 
understand where and how tile beds act as sources of PhACs as a way to ultimately 
understand the impact of such contaminants on groundwater and drinking water supplies.  In 
this study, several of the pharmaceuticals were detected in groundwater at distances as far as 
30 m from the tile beds.  These observations have implications for Ontario drinking water 
and well installation regulations.  According to the Ontario Water Resources Act (R.R.O. 
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1990, Regulation 903), any new, undrilled well must be at least 30 m from a potential source 
of contamination, such as a tile bed.  The findings in this study indicate the possibility that 
drugs, such as carbamazepine and ibuprofen, could be found in drinking water supplies for 
water wells located 30 m from septic system tile beds.  The likelihood of drugs entering 
drinking water supplies would be further enhanced in settings where groundwater velocities 
would be increased due to high rates of groundwater withdrawal or high loading from tile 
beds.  Concentrations for these PhACs were in the µg L-1 range in groundwater, markedly 
lower than maximum daily adult dosages which range from1,200 to 3,200 mg for the PhACs 
in this study (RxList Inc., 2008).  While the groundwater concentrations found in this study 
appear to pose little risk to adults when considering typical daily dosages, the same may not 
be true for fetuses or children who are more vulnerable to low PhAC exposure given the 
nature of their development and metabolic systems.  Children have been found to have a 
greater risk of adverse effects resulting from exposure to PhACs, and also have the potential 
risk of being exposed to PhACs not designed for pediatric care (Collier, 2007).  Additionally, 
unintentional exposure of PhACs in trace concentrations can be harmful to pregnant women 
and their developing fetus.  Over the course of a pregnancy, women are inadvertently 
exposed to a number of drugs that are capable of causing birth defects, and it has been 
estimated that women can ingest close to thirteen percent of a single dose over a 36 week 
period (Collier, 2007).  In addition, the ability for PhACs to have additive effects identifies 
the possibility for concentrations to be considered environmentally relevant to a variety of 
other organisms.  Finally, this study suggests that PhACs may be used as highly sensitive 
tracers or indicators of urban pollution. 
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2.4 Conclusions & Recommendations 
The septic system at the Long Point Provincial Park acts as a source of the pharmaceutical 
compounds carbamazepine, ibuprofen, naproxen, caffeine, sulfamethoxazole and gemfibrozil 
to groundwater.  The drug that appeared to be the most persistent and recalcitrant in this 
environmental setting was carbamazepine, with detections as far as 30 m from the septic bed 
infiltration zone.  However, in the saturated zone all drugs showed at least some degree of 
attenuation, with ibuprofen, naproxen, caffeine, gemfibrozil and sulfamethoxazole being 
more greatly retarded along the primary groundwater flow direction than carbamazepine.  
This assessment of attenuation assumes a constant source, and is affected by the varying 
detection limits of each PhAC.  Maximum groundwater concentrations were 2,050 ng L-1 
(carbamazepine), 1,990 ng L-1 (sulfamethoxazole), 160 ng L-1 (caffeine), 1,790 ng L-1 
(ibuprofen), 625 ng L-1 (naproxen) and 10 ng L-1 (gemfibrozil).  Dispersive dilution was 
found to be a relatively minor process in the aquifer across the distance studied, and 
therefore, other processes likely contribute to the attenuation of these non-conservative 
drugs.  As attenuation was difficult to predict by examining properties such as the pKa, log 
Dow and R, other processes such as ion exchange or more complex adsorption reactions and 
the potential for degradation may be important in determining fate and transport 
interpretation.  Consideration of the degree of dissociation of each pharmaceutical compound 
was also considered relevant in this investigation.  Further studies such as column 
investigations would assist in delineating specific processes that affect transport of PhACs in 
this and other aquifer systems.  Analysis of additional tank samples would provide an 
indication of the constancy in tank concentrations. 
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A brief investigation of transport across the unsaturated zone illustrated that most of the 
drugs exhibit a much larger decrease in concentration across the unsaturated zone than the 
conservative tracer (Cl).  This interpretation assumes relatively constant concentrations for 
all PhACs within the septic tank.  In particular, ibuprofen, caffeine and naproxen had the 
greatest difference in concentrations between the tank and the groundwater, suggesting a 
high level of removal in the unsaturated zone.  Therefore, degradation, biodegradation and/or 
sorption processes play an important role in the fate and transport of these PhACs in the 
unsaturated zone.  As a result, additional laboratory and field studies on this subject are 
recommended, as in most environmental settings, contaminants pass through the unsaturated 












Weight      
g mol-1 log Kow 
Solubility 
(mg L-1)  pKa 
Carbamazepine Anticonvulsant,  298-46-4 C15H12N2O 236.27 2.45 17.7 13.9 
Carbamazepine d10 antidepressant 132183-78-9 C15H2N2OD10 
 
246.33    
         
Sulfamethoxazole Antibiotic 723-46-6 C10H11N3O3S 253.28 0.89 610 6 
Sulfamethoxazole d4 n/a C10H7D4N3O3S 257.3    
    
 
    
Caffeine Stimulant 58-08-2 C8H10N4O2 194.19 -0.07 21,600 10.4 
Caffeine d3  26351-03-1 C8H7N4O2D3 
 
197.21    
        
Gemfibrozil   Lipid regulator 25812-30-0 C15H22O3 250.33 4.77 19 4.75 
Gemfibrozil d6  25812-30-0 C15H16O3D6 
 
256.37    
         
Naproxen Non-steroidal 22204-53-1 CH3OC10H6CH(CH3)CO2H 230.26 3.18 
Naproxen 13C anti-
inflammatory 
    
15.9 4.15 
    
 
    





209.3    
Table 2.1 – Pharmaceuticals of interest, along with their chemical properties (Trenholm et al., 2006) and structures.  Also provided are 
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Carbamazepine Positive 0.1 - 20 0.9996 96-104 3/37 0.2/2.2 
       
Sulfamethoxazole Positive 0.1 - 20 0.9995 95-105 23/78 1.4/4.6 
       
Caffeine Positive 0.1 - 20 0.9995 94-104 0/20 0/1.2 
       
Gemfibrozil   Negative 0.1 - 20 0.9995 95-107 15/65 0.9/4 
       
Naproxen Negative 0.1 - 20 0.9994 95-105 139/763 8/45 
       
Ibuprofen Negative 0.1 - 60 0.9994 92-109 189/648 11/38 
Table 2.2 – Method Calibration.  For all the drugs analysed in negative ESI mode, selected 
samples were analyzed using three separate calibrations.  The information provided is 
representative of all three analysis runs.  All calibrations were performed using a linear 
regression with at least 8 calibration points, and a weighting factor of 1/x2.  The accuracy of 
the calibrations illustrates how close the measured concentration of each standard was to the 
expected concentration.  The instrument method detection limit (MDL) and limit of 
quantification (LOQ) indicate the sensitivity of the analytical method.  The Method MDL 




Accuracy of Blind 
Spikes (%) and 
%RSD 
Blanks (Lab and Field, and 





Carbamazepine 100 +/- 3 < 0.2 ng L-1 0.4 +/- 0.4 
    
Sulfamethoxazole 101 +/- 2 < 1.4 ng L-1 4.3 +/- 5.1 
    
Caffeine 101 +/- 3 trace peak 3 +/- 4.3 
    
Gemfibrozil   117 +/- 10 < 0.9 ng L-1 8.2 +/- 5.9 
    
Naproxen 103 +/- 10 < 8 ng L-1 4.8 +/- 4.2 
    
Ibuprofen 102 +/- 7 < 11 ng L-1 2.8 +/- 3.2 
 n = 3  n = 3 
Table 2.3 – Quality Assurance and Quality Control.  The accuracy of the blind spiked 
samples were measured by comparing the measured concentration to the expected 
concentration.  Blank samples were analysed throughout each analytical run.  The average 
percent difference between duplicates samples was calculated, and the standard deviation is 





Recovery of IS 
in Method 








Standards (%) % RSD 
Carbamazepine 86 8 86 9 99 7 
       
Sulfamethoxazole 140 9 151 17 107 7 
       
Caffeine 116 6 126 6 107 2 
       
Gemfibrozil   82 16 101 21 122 9 
       
Naproxen 86 16 103 26 119 20 
       
Ibuprofen 99 13 102 16 102 7 
 n = 4  n = 4  n = 4  
Table 2.4 – The absolute recovery of each internal standard (IS), analyte and relative 
recovery, and the per cent relative standard deviation (%RSD) is noted for method standards.  
Method standards were prepared at four analyte concentrations (0.2, 0.5, 1.0, 5.0 μg L-1) and 
consisted of Milli-Q samples spiked prior to SPE with analytes and internal standards.  
Absolute IS recoveries was determined by comparing the peak area of the internal standard in 
the method standards, to the peak area of the internal standard in the calibration standards.  
For recovery of the analyte, the same practice was employed by comparing analyte peaks 
rather than internal standard peaks.  In addition, the relative recovery, which considers the 
ratio of the analyte to that of the internal standard is provided for the method standards, 
which is representative of the final accuracy in the calculation of analyte concentrations.  








of IS (%)  %RSD 
Relative 
Recovery of 
Blind Spikes (%) %RSD 
Carbamazepine 69 13 100 4 
     
Sulfamethoxazole 96 20 100 2 
     
Caffeine 89 16 102 2 
     
Gemfibrozil   97 7 109 2 
     
Naproxen 84 7 99 11 
     
Ibuprofen 90 11 99 12 
 n = 41  n = 3  
Table 2.5 – Sample recovery data.  The recovery of each internal standard (IS), and the 
percent relative standard deviation (%RSD) is noted for all unknown samples.  Recovery was 
determined by comparing the peak area of the internal standard in unknown samples, to the 
peak area of the internal standard in the calibration standards.  In addition, the relative 
recovery, which considers the ratio of the analyte to that of the internal standard is provided 
for the blind spiked samples, which were a set of quality control standards spiked to known 
analyte concentrations, and then processed through solid phase extraction (SPE) and HPLC-









(m bgs) ng L-1 ng L-1 ng L-1 ng L-1 ng L-1 ng L-1 
        
Tank  77 635 7530 29350 1235 < 1 
        
LP-120 2.8 19 11 20 336 < 8 8 
 2.8 19 11 - 337 < 8 8 
 3.4 460 316 11 231 12 9 
 3.9 1070 207 47 618 121 1 
 4.6 747 196 19 265 40 <1 
 5.3 476 < 1.4 < 1 12 < 8 <1 
        
LP-121 2.6 291 22 9 19 < 8 < 1 
 3.2 771 455 < 1 116 31 2 
 3.8 1280 600 48 18 43 5 
 4.4 829 706 54 1210 151 1 
 5 835 4 46 233 7 1 
        
LP 122 2.8 460 478 66 3 < 8 < 1 
 3.4 929 92 14 14 19 1 
 4.6 959 323 106 33 39 1 
 5.2 - - - - - - 
        
LP-123 2.6 435 255 19 7 < 8 < 1 
 3.2 824 86 2 107 52 2 
 3.8 1510 560 77 1790 309 9 
 4.5 16 7 9 117 88 3 
        
LP-138 1.9 788 26 13 3 < 8 < 1 
 2.3 2050 1990 159 870 624 5 
 2.7 408 6 6 759 23 6 
 3.1 564 9 7 624 88 10 
        
LP-136 1.9 40 14 11 < 11 < 8 < 1 
 2.3 431 46 32 8 15 1 
 2.7 465 58 20 12 32 1 
 3.1 - - - - - - 
        
LP-124 1.6 22 9 < 1 5 < 8 < 1 
 2.1 173 33 2 4 < 8 < 1 
 2.6 134 < 1.4 9 19 < 8 < 1 
 3.1 103 3 2 4 < 8 < 1 
  3.6 155 < 1.4 48 21 < 8 < 1 
Table 2.6 – Concentrations of the pharmaceuticals carbamazepine (CBZ), sulfamethoxazole 
(SMX), caffeine (CAF), ibuprofen (IBU), naproxen (NAP) and gemfibrozil (GEM) in 
groundwater and the septic tank at the Long Point septic system plume.  If not detected, 
concentration is listed to be below the method detection limit (MDL).  If sample was not 





Figure 2.1 – Geochemical parameters in the groundwater downgradient of the Long Point 
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Figure 2.2 – Depth (m) profiles for geochemical parameters at sampling points downgradient 
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Figure 2. 3 – Absolute method recovery for analytes and internal standards (IS) for 
carbamazepine (CBZ), sulfamethoxazole (SMX), caffeine (CAF), gemfibrozil (GEM), 
naproxen (NAP), and ibuprofen (IBU) is plotted.  Recoveries were calculated by comparing 
the peak area of each analyte or IS in a set of method standards, to the peak area found in the 
calibration standards.  The relative recovery, which considers the ratio of the analyte to that 
of the internal standard, is also provided, and illustrates the degree to which the use of 
isotope dilution techniques help to correct poor recoveries.  Standard deviations are plotted 





Figure 2. 4 - Groundwater plumes downgradient of the Long Point septic tile bed for the 
pharmaceuticals of interest; carbamazepine (CBZ), ibuprofen (IBU), sulfamethoxazole 
(SMX), naproxen (NAP), caffeine (CAF), and gemfibrozil (GEM), as well as the 
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Figure 2. 5 – Depth (m) profiles for pharmaceutical compounds of interest carbamazepine 
(CBZ), sulfamethoxazole (SMX), caffeine (CAF), ibuprofen (IBU), naproxen (NAP) and 





Figure 2. 6 – pKa of each pharmaceutical of interest plotted on the pH scale.  The pH range of 









































Figure 2. 7 – Log Dow calculated for each pharmaceutical of interest calculated across the 
entire pH range.  The pH range at the Long Point Septic site is between 6.7 and 7.2 (Carrara 
et al., 2008). Retardation coefficients (R) calculated using the Dow values, presented over the 








Municipal landfill waste disposal sites have been identified as sources of contamination to 
groundwater.  Some of the more common contaminants include dissolved organic carbon 
(DOC), NH4, benzene, toluene, and aromatic hydrocarbons (Christensen et al., 2001).  
However, specific contaminants observed in leachate plumes vary from site to site depending 
on the type of waste deposited, the control measures in place, and the site hydrogeology and 
geochemistry. 
 
The properties of leachate are determined by the type of waste deposited (Christensen et al., 
2001).  This leachate will migrate downward through the base of the landfill if a leachate 
collection system or leachate liner is not 100% effective, or in the case of older landfills, if 
there are no leachate control measures in place.  After leachate leaves the waste pile, it often 
infiltrates through the unsaturated zone, eventually forming a plume of groundwater 
contamination.  The transport of this plume is strongly controlled by the geochemical 
properties of the site, including pH and oxidation-reduction conditions (Christensen et al., 
2001; Bjerg et al., 2005). 
 
3.1.1 Waste Disposal Patterns 
Disposal patterns of unused or expired medications appear to be dependant on the habits of 
the patient, the type of drug, and the rate of prescription and drug consumption (Bound and 
Voulvoulis, 2005).  Bound et al. (2006) observed that for a U.K. sample population of 400 
households, 63.2 % of people surveyed had disposed their drugs in the municipal waste 
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stream, and 11.5 % had deposited them into their household grey or black water.  A follow-
up study conducted by Slack et al. (2007b) in the U.K. found that from a survey of 500 
homes, 55.8 % of survey participants had disposed of their drugs into the municipal waste 
stream, while only 9.9 % had disposed of drugs down the drain.  From this information, it 
was estimated that 280 T of medicinal waste enters municipal landfills each year in the UK.  
In the U.S., new federal guidelines have been issued to minimize disposal of pharmaceutical 
waste down the drain, instead favouring disposal in municipal waste streams (Halford, 2008), 
potentially resulting in an increase in the proportion of pharmaceutically active compounds 
(PhACs) that are landfilled.  In addition to disposal of unused or expired drugs, human or 
veterinary drugs may also be present in the municipal waste stream as a result of the disposal 
of human and pet feces and urine.  Overall, there is evidence that PhACs are being deposited 
into municipal waste streams, and will likely continue to be a part of household waste into 
the future. 
 
3.1.2 Pharmaceuticals in Groundwater 
The presence of PhACs has been studied in groundwater and surface water with possible 
sources being identified in Figure 1.1.  The study of pharmaceuticals in groundwater has 
received less attention than pharmaceuticals in surface water, but in recent years, the number 
of studies documenting the presence of pharmaceuticals in groundwater has been increasing.  
Some of the identified sources to groundwater include bank infiltration (Kreuzinger et al., 
2004; Massmann et al., 2008), artificial groundwater recharge (Drewes et al., 2002), 
agricultural infiltration (Heberer et al., 1998; Scheytt et al., 2007; Siemens et al., 2008), 
septic systems (Conn et al., 2006; Swartz et al., 2006; Godfrey et al., 2007; Carrara et al., 
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2008), leaky sewer systems (Fenz et al., 2005) and landfills (Eckel et al., 1993; 
Schwarzbauer et al., 2002; Holm et al., 1995).   
 
Godfrey et al. (2007) observed pharmaceuticals including carbamazepine and 
sulfamethoxazole at concentrations up to 450 ng L-1 in a shallow aquifer below a high school 
septic bed in Montana.  The same study also detected pharmaceuticals in groundwater below 
an urban area containing multiple residential tile beds at concentrations less than 25 ng L-1, 
with the exception of caffeine that was found to have a maximum concentration of 206 ng L-1 
(Godfrey et al., 2007).  Carrara et al. (2008) found evidence that septic beds can act as 
sources of PhACs to groundwater.  An evaluation of groundwater downgradient of a tile bed 
in Long Point, Ontario detected the presence of several pharmaceutical compounds having 
maximum concentrations in the range of 20 to 12,000 ng L-1.  Siemens et al. (2008) observed 
a variety of drugs including ibuprofen and naproxen in shallow groundwater below an 
irrigation field.  Caffeine was detected in groundwater in a variety of settings, including 
below an agricultural field irrigated with sewage effluent (40 ng L-1) and in a monitoring well 
below an urban subdivision contaminated with domestic waste water (230 ng L-1), where 
caffeine was also detected (Seiler et al., 1999).  Carbamazepine was found entering 
groundwater through leaky sewage systems, resulting in a maximum average groundwater 
concentration of 30 ng L-1 (Fenz et al., 2005).  Carbamazepine was also observed in 
groundwater being infiltrated with sewage effluent, suggesting that it was resistant to 
attenuation in the unsaturated zone (Seiler et al., 1999; Kreuzinger et al., 2004).  Ibuprofen 
and carbamazepine were detected in groundwater as a result of groundwater recharge 
(Drewes et al., 2003).  Groundwater below two golf courses irrigated with treated wastewater 
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had detectable amounts of carbamazepine and caffeine, and sulfamethoxazole, ibuprofen, 
gemfibrozil and carbamazepine were found in groundwater at the ng L-1 range below a 
receiving and holding pond for treated wastewater (Snyder et al., 2004).  Therefore, a variety 
of field studies have detected measurable concentrations of various pharmaceutical 
compounds in groundwater settings, identifying a variety of different sources, and the ability 
of PhACs to be present and persist in groundwater environments.  
 
3.1.3 Pharmaceuticals in Landfills 
The potential contamination of groundwater as the result of pharmaceutical disposal in 
sanitary landfills has been postulated by a number of investigators (Heberer, 2002; Bound 
and Voulvoulis, 2005; Doerr-MacEwan and Haight, 2006; Seeusen and Edwards, 2006; 
Nikolaou et al., 2007), however, there are limited studies documenting pharmaceutical 
occurrence in leachate plumes.  One of the first studies to find the presence of a 
pharmaceutical compound downgradient of a landfill qualitatively identified three 
compounds at concentrations up to 1 μg L-1 at a single well 300 m away from the landfill in a 
shallow sandy aquifer (Eckel et al., 1993).  This study indicated the potential for landfills to 
leach pharmaceuticals into groundwater, and therefore identified the need for further studies.  
Holm et al. (1995) looked for the presence of pharmaceuticals downgradient of a landfill 
used for waste disposal from the pharmaceutical industry.  Close to the landfill, sulfonamides 
reached concentrations upwards of 6,470 μg L-1.  All drugs detected appeared to become 
fully attenuated and were non-detectable 150 m away from the landfill.  A screening for 
several pharmaceuticals was performed at a landfill that had high rates of seepage into 
groundwater due to minimal bottom sealing (Schwarzbauer et al., 2002).  The leachate 
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entered a former mining system consisting of shafts and tunnels situated below the waste 
pile.  Ibuprofen, clofibric acid and propylphenazone were detected in all samples collected at 
concentrations as high as 140 μg L-1.  More recently, Ahel et al. (2004) observed PhACs in 
landfill leachate and groundwater samples at a municipal landfill accepting industrial waste.  
The PhACs were intermediates developed from the synthesis of vitamin C.  A study 
conducted by Barnes et al. (2004) discovered PhACs including triclosan in relatively shallow 
wells downgradient of an old, unlined municipal landfill.  Overall, information on the fate of 
PhACs in properly engineered municipal landfills or landfills that are not accepting wastes 
from the pharmaceutical industry appears limited.  
 
3.1.4 Purpose of Study 
Based on the volumes used, the disposal patterns, and the biologically active nature of 
pharmaceuticals, it is important to investigate the possibility of pharmaceuticals emanating 
from landfills in groundwater plumes. The current literature reflects a bias towards research 
on wastewater treatment plants as sources, rather than landfill leachate (Bound and 
Voulvoulis, 2005), and therefore the risks of pharmaceuticals to the environment may not be 
fully understood.  This current study was conducted in an attempt to overcome the apparent 
gap in research by investigating the possibility that engineered municipal landfills can act as 





3.2.1 Site Descriptions 
The Cambridge landfill is located within Cambridge, Ontario, Canada.  The site is 123 
hectares, of which 38 are licensed for non-hazardous waste disposal.  The landfill accepted 
primarily domestic waste, as well as some commercial and industrial waste from the time it 
opened in 1973, to when it closed and was capped in 2003.  Upon closure the landfill had 
reached a final capacity of 2,650,000 tonnes of waste.  Initially constructed without a 
leachate containment system, it was gradually upgraded to meet design requirements.   It is a 
geologically complex site, with strata from surface downward being: silts and sands, clayey 
silts/sands, sand/silty sand till, sand and gravel, and bedrock.  The clayey silt layer is not 
continuous throughout the site, but where present acts as a confining layer and allows for the 
presence of a shallow perched aquifer.  The regional aquifer, and the one which nearby 
municipal supply wells draw their water from, is located within the deep sand and gravel 
unit, with the water table being approximately 20 m below the base of the waste pile.  
Groundwater flow in the regional aquifer is generally towards the west, however, 
containment pumping wells have influenced parts of the local groundwater flow direction 
(CH2MHILL, 2008) 
 
The Waterloo landfill is located in Waterloo, Ontario, Canada. The original landfill was in 
operation from 1972-2002, and currently an expansion cell directly north of the original 
landfill is being filled, with additional expansion cells being constructed.  In 2007, the year in 
which sampling occurred, 244,000 tonnes of refuse was accepted at the site. The base of the 
original landfill is 0.25 km2 in area, and the height of the waste pile is up to 30 m.  The water 
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table is located 30 m below the base of the pile.  Directly below the surface, there is an upper 
fine-grained till unit extending from 1 m to 30 m deep.  Previously, a detailed network of 
monitoring wells was installed around the landfill, throughout the property, and on other 
properties downgradient and upgradient of the landfill.  Groundwater flow is from west to 
east below the landfill (Region of Waterloo, 2008). 
 
3.2.2 Field Methods 
The sampling at the Cambridge Landfill was conducted in June 2007.  A total of 31 wells 
were sampled (Figure 3.1), each located within an associated leachate plume.  Thirteen of 
these wells were located within a plume extending to the northwest of the site along transect 
C-C’.  The wells sampled contained concentrations of vinyl chloride, 1,1-DCA, and benzene, 
and were also selected due to their relative proximity to a municipal drinking water supply 
well.  The remaining 18 wells were selected based on the presence of a leachate plume 
flowing to the southwest along transect D-D’.  The wells sampled were selected based on 
concentrations of benzene, vinyl chloride, 1,1-DCA and chloride.  Several of the wells 
sampled within this area were influenced by a pumping containment system.  A total of 4 
leachate wells located directly in the refuse were sampled.  The remaining wells were all 
considered groundwater wells and were outside the limit of refuse. 
 
Sampling at the Waterloo Landfill was conducted during July, 2007.  Twenty-three wells 
were selected for sampling.  Of these, 19 were located along  transect A-A’ (Figure 3.2), 
which runs along the northeast side of the original landfill and extends approximately 600 m 
downgradient of the edge of the pile.  The other four sampling points were located in the 
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west corner of the landfill, and were selected based on locations where high concentrations of 
vinyl chloride were observed, indicative of contamination derived from the landfill. 
 
Samples were collected from piezometers with dedicated polyethylene tubing using a 
Waterra pump powered by a portable gasoline generator.  At the Waterloo Landfill, some of 
the wells sampled were groundwater extraction wells, and as a result are continually purged 
and were sampled directly from a pre-configured tap.  Samples were collected for PO4-P, 
CH4, pharmaceuticals, metals, DOC, NH3/NH4-N, and anions.  All samples were filtered in 
the field using high capacity Wattera 0.45 μm filters.  They were collected in HDPE Nalgene 
bottles, with the exception of the pharmaceutical samples, which were collected in amber 
glass bottles to prevent photodegradation and sorption to plastics, and the methane samples, 
which were collected in 20 mL septum-capped glass vials.  Methane samples were collected 
by hand pumping the well to fill the polyethylene tube, then gently pouring the water into the 
vial to reduce introduction of air into the sample.  Samples for analysis of pharmaceuticals, 
NH3/NH4-N, and PO4-P were preserved in the field by acidifying to a pH < 2 using 16N 
H2SO4.  Metals samples were preserved to a pH < 2 using 6N HNO3.  At each well, pH test 
strips were used to verify that the proper pH was achieved during the acidification process. 
 
Groundwater temperature, pH, Eh, alkalinity, and dissolved oxygen (DO) (Waterloo Landfill 
only) were measured directly in the field using standard procedures.  Alkalinity 
measurements were performed in the field using a Hach digital titrator.  Filtered samples 
were titrated with 1.6 N H2SO4, using bromocresol green-methyl red indicator.  A digital 
thermometer was used to determine the temperature of the groundwater.  Measurements of 
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Eh and pH were made in a sealed flow-through cell using the slowest flow rate possible with 
the Wattera pump.  The water for these measurements was unfiltered, with the exception of 
wells with particularly turbid water.  The temperature of the flow through cell was 
maintained near groundwater temperatures through the use of an ice bath.  An Orion Thermo 
Sure-Flow combination redox electrode and an Orion Thermo Ross combination electrode 
were used to measure Eh and pH.  The electrodes were calibrated prior to sampling at each 
well using Zobell’s  and Light’s solutions for the Eh electrode, and standard buffer solutions 
of pH 4 and 7, and checked against a pH 10 buffer for the pH electrode.  Values for DO were 
approximated through the use of CHEMets® kits.  At each field site, approximately 1 blind 




Drug standards for carbamazepine, gemfibrozil, naproxen, sulfamethoxazole, ibuprofen and 
caffeine were obtained from Sigma Aldrich Canada.  For each analyte, a unique internal 
standard was used that was the same compound, with only a slight difference in properties 
due to a small change in the mass number as a result of it being labeled with an isotope.  
Table 2.1 outlines the unique internal standards used for each analyte, together with the 
properties of each analyte and internal standard.  All internal standards were obtained from 
CDN Isotopes (Quebec, Canada) with the exception of sulfamethoxazole d4 (Toronto 




Nanopure water (Milli-Q water) was provided through the use of a 0.45 μm Millipore Q-
Gard1 unit.  High performance liquid chromatography (HPLC) grade methanol (MeOH) 
(99.9%), ammonium acetate, formic acid, acetic acid and acetonitrile were obtained from 
Caledon Laboratories Ltd. (Georgetown, ON, Canada).  
 
All pharmaceutical stock solutions were prepared by measuring 10 mg of either an analyte or 
an internal standard and dissolving in MeOH/Milli-Q water (50:50 v/v), with the exception of 
gemfibrozil and its internal standard (gemfibrozil d6), which were dissolved in 10% 0.03M 
NaOH in MeOH/nanopure water (50:50 v/v), and internal standards for ibuprofen and 
naproxen, which were dissolved in pure MeOH.  The solvent selected was based on the 
solubility properties of each pharmaceutical. 
 
3.2.4 Sample Preparation 
Samples stored at 4°C were allowed to reach room temperature.  Frozen samples were 
allowed to thaw to room temperature, and were vacuum filtered using 0.45 μm nylon filters 
to prevent clogging of the solid phase extraction (SPE) cartridges by a gel residue that 
formed as a result of freezing.  A sorption study was conducted that evaluated the loss of the 
analytes onto the nylon filters.  The results indicated that there was minimal to no sorption of 
all pharmaceuticals to the nylon filters (Hebig, 2008) and therefore it is not expected that this 
step will have affected the aqueous concentrations of the PhACs of interest.  A laboratory 




One hundred mL of each sample was spiked prior to SPE with a mixture containing all six 
internal standards to achieve a concentration of 1 μg L-1 of each internal standard after the 
SPE step.  Unique internal standards were utilized for each analyte to account for analyte 
losses during the SPE step and matrix suppression during analysis.  Utilizing a unique 
internal standard for each pharmaceutical provides the most accurate representation of the 
unknown analyte to correct for losses during SPE, instrument suppression and other errors 
during analysis (Gros et al., 2007).  
 
Solid phase extraction was performed using Oasis HLB 5 mL glass cartridges under 
approximately 13 cm (5 in.) Hg of vacuum.  These cartridges have been used previously with 
success for PhAC analysis in environmental applications (Hao et al., 2006; Vanderford and 
Snyder, 2006; Feitosa-Felizzola et al., 2007; Gros et al., 2007; Díaz-Cruz et al., 2008).  
Cartridges were conditioned with 3 mL of HPLC grade MeOH and equilibrated with 3 mL 
Milli-Q water.  The cartridges were loaded with the samples and washed using 3 mL of 5% 
MeOH (v/v).  Finally, the cartridges were eluted with three repeats of 2 mL of MeOH.  The 
eluate was collected in a glass amber bottle and stored at 4°C until time of analysis.  Use of 
SPE cartridges serves two purposes, 1) impurities are removed from the samples to minimize 
instrument contamination and interferences during analysis, and; 2) the samples are 
concentrated to improve detection limits.  In this study, 100 mL of sample was concentrated 
to 6 mL, yielding a concentration factor of approximately 17.  A set of blind spiked 
laboratory samples were prepared with analyte concentrations of 0.1 μg L-1, 0.5 μg L-1, and 
1.0 μg L-1.  The purpose of these spiked samples was two-fold, first to evaluate the analysis 
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and calibration of the MS/MS method, and secondly to evaluate the recovery of analytes and 
surrogate internal standards passing through the SPE cartridges.  
 
Samples that were frozen were extracted within 10 months, and all samples extracted in 
MeOH were analyzed within 6 months.  A series of extractions on duplicate samples were 
performed over the 10 month period, with good reproducibility between separate analyses.  
In addition, results were reproducible between identical samples reanalyzed after being 
stored in MeOH between 0 to 6 months. 
 
3.2.5 Pharmaceutical Analytical Methods 
Analysis for pharmaceutical compounds was performed using high performance liquid 
chromatography electrospray tandem mass spectrometry (HPLC-ESI-MS/MS).  The HPLC 
was an Agilent 1100 series operated using an eluant gradient.  The mass spectrometer was an 
Applied Biosystems MDS SCIEX 4000QTrap.  The nebulizer gas at the ionization source 
and the collision gas used to fragment the parent ion was N2.  A multiple reaction monitoring 
scan (MRM) was utilized for quantification, which occurred through a signal ratio between 
the analyte peak to that of the corresponding internal standard. 
 
The analytical procedures utilized were modified from procedures described by Vanderford 
et al. (2003) and Stafiej et al. (2007).  Analyses of caffeine, carbamazepine and 
sulfamethoxazole were conducted in positive ESI mode.  A Symmetry RP18 column (Waters 
Corporation, Mississauga, ON, Canada) was used with a length of 50 mm, an internal 
diameter of 4.6 mm, and a particle size of 3 μm.  The flow through the column was 1.25 mL 
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min-1, with an injection volume of 15 μL.  Mobile phase A consisted of 5 mM ammonium 
acetate and 0.1 % formic acid in nanopure water.  Mobile phase B was 100 % MeOH with 
0.1 % formic acid.  The gradient started at 15 % for mobile phase B, after 0.76 min increased 
to 100 %, then at 2.5 min decreased back to 15 % until 4 min was reached.  
 
Naproxen, gemfibrozil, and ibuprofen were analysed in negative ESI mode.  An XDB-C18 
column (Agilent Technologies, Mississauga, ON, Canada) with a length of 150 mm, an 
internal diameter of 4.6 mm and a particle size of 5 μm was used.  The flow rate through the 
column was 1 mL min-1, with a total injection volume of 10 μL.  Mobile phase A, at pH 4, 
was 30 % acetonitrile diluted with nanopure water with 6.9 mM acetic acid.  Mobile phase B 
was 100 % acetonitrile.  The gradient started at 0 % of mobile phase B, at 18 min increased 
to 3 %, at 22 min to 12%, 40 min to 40 %, and ended at 45 min at 0 %. 
 
3.2.6 Calibration 
Instrument calibration was performed using an 8-point linear regression and a weighting 
factor of 1/x2, with a linear correlation coefficient of at least 0.999 (Table 3.1).  The 
accuracies of most calibrations standards used were 100 +/- 5% (Table 3.1).  Accuracy is a 
measure of how close the calculated (measured) value was for each calibration standard, to 
the expected concentration.  The method detection limit (MDL) and limit of quantification 
(LOQ) were determined using a signal-to-noise ratio with a standard deviation of 3, where a 
signal to noise ratio of 3 was used to calculate the MDL and 10 was used to calculate the 
LOQ.  Instrument detection limits are provided in Table 3.1, together with method detection 
limits that are corrected for the SPE concentration factor.  The concentrations were calculated 
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using the external calibration curve, which were then corrected using the measured responses 
for the internal standards added to each sample.  
 
3.2.7 Geochemical Analytical Methods 
Methane samples were analyzed within 7 days of collection using head-space analysis gas 
chromatography with a flame-ionization detector (GC/FID) and a method modified from 
Blicher-Mathiesen et al. (1998).  Determinations of ammonia concentrations were made 
using automated colorimetric procedures at an external laboratory.  Phosphate determination 
was done spectrophotometrically with a HACH DR/2010 at 880 nm using the HACH 
ascorbic acid - molybdenum blue method.  Anion concentrations were performed using ion 
chromatography.  For the Cambridge Landfill, blind duplicates for all geochemical 
parameters were consistent, with the average percent difference being 3.3 %.  In addition, the 
field blank was below method detection limits for all geochemical parameters with the 
exception of Cl and SO4, which had measurable concentrations.  The Waterloo Landfill 
duplicate analyses were also consistent, with an average percent different for all geochemical 
parameters being 10.5 %. 
 
3.3 Results and Discussion 
3.3.1 Geochemical Setting  
Results of chemical analyses at the Cambridge landfill site were plotted along two cross 
sections.  The first cross section (C-C’), extends approximately 400 m, and begins with a 
well drilled directly through the refuse at the top of the waste pile.  Several parameters (Eh, 
alkalinity, anions) were not analyzed for the leachate wells due to the high organic content of 
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the samples.  Figure 3.3 illustrates the geochemistry at the site (Appendix D).  The pH and 
Eh values generally were lowest close to the landfill (6.45 and 18 mV, respectively), 
increasing in value downgradient from the landfill.  The pH was acidic to neutral close to the 
landfill, and became more basic in a downgradient direction.  Concentrations of alkalinity, 
Cl, CH4, DOC, NH3/NH4-N all decreased with an increase in distance from the landfill.  
Maximum concentrations were 1,624 mg L-1 as CaCO3 (alkalinity), 508 mg L-1 (Cl), 10.5 mg 
L-1 (CH4), 65.4 mg L-1 (DOC), 46.6 mg L-1 (NH3/NH4-N).  NO3 was not observed in 
measurable concentrations (<0.4 mg L-1) at any sampling location, whereas SO4 only 
appeared at elevated concentrations 150 m downgradient from the landfill (up to 792.6 mg L-
1).  Concentrations for PO4-P were very low across the entire cross sections, with a maximum 
concentration of 0.08 mg L-1. 
 
The second cross section (D-D’) sampled at the Cambridge Landfill extends approximately 
800 m, and begins with a well drilled directly through the refuse at the top of the waste pile, 
and ends approximately 500 m past the limit of refuse.  No distinct trend was observed for 
pH, with values ranging from 6.47 to 7.79 along the plume.  In general, Eh measurements 
were lowest in the deepest wells and closer to the landfill; and further downgradient from the 
landfill, values increased.   
 
Concentrations were generally low close to the water table, particularly for Cl, possibly 
indicating that some of the wells sampled closest to the landfill were located on the fringe of 
the plume and not necessarily indicative of the plume core.  Leachate plumes are typically 
narrow (Christensen et al., 2001), further suggesting that this is the case.  In addition, Eh and 
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alkalinity were not measured in the three leachate wells sampled along this cross section.  
The concentration distributions are illustrated in Figure 3.4.  DOC, alkalinity, Cl, CH4, 
NH3/NH4-N, and PO4-P were generally found to have higher concentrations in the wells 
closest to the landfill, and decreased away from the landfill due to redox processes such as 
nitrification and oxidation of organic matter, and/or mechanical dispersion.  Maximum 
concentrations for these parameters were 881 mg L-1 (DOC), 1,052 mg L-1 as CaCO3 
(alkalinity), 652.3 mg L-1 (Cl), 17 mg L-1 (CH4), 1,550 mg L-1 (NH3/NH4-N) and 1.72 mg L-1 
(PO4-P).   NO3-N was only detected at a single location approximately 200 m downgradient 
from the landfill (1.53 mg L-1), likely as a result of oxidation of NH3/NH4-N, and SO4 
concentrations tended to be highest 200 m downgradient, with a maximum measured 
concentration of 58.7 mg L-1.  These trends are consistent with redox processes occurring in 
the denitrification zone, where the oxidized species SO4 and NO3-N would typically be 
observed downgradient from the landfill (Bjerg et al., 2005). 
 
At the Waterloo landfill, geochemical analyses (Appendix E) were determined for a single 
cross section (A-A’) (Figure 3.5) and are presented in Figure 3.6.  In this cross section, many 
of the wells extended along the edge of the landfill, but were not located directly below the 
waste pile and are therefore considered groundwater wells and not leachate wells.  Wells 
sampled extend approximately 800 m downgradient from the limit of refuse.  In general, pH 
and Eh were found to be lowest closer to the landfill (6.1 and 37 mV, respectively), and 
increased further downgradient and with greater depth below the waste pile.  Similar to the 
Cambridge site, values for alkalinity (760 mg L-1 as CaCO3), Cl (58.34 mg L-1), CH4 (19.5 
mg L-1), PO4-P (0.027 mg L-1) and DOC (55.3 mg L-1) were highest closer to the landfill, and 
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decreased moving downgradient from the landfill.  Sulfate was found in nearly all wells, 
however, the highest concentrations were found in wells located downgradient of the waste 
pile (67.7 mg L-1).  Concentrations of NO3-Ns were observed below detection (0.4 mg L-1) in 
all wells with the exception of two located approximately 500 m downgradient of the landfill, 
which is similar to findings across Cambridge cross section D-D’ where NO3 was only 
present in one well downgradient of the waste pile.  NH4/NH3-N was only detected in one 
well near the waste pile (0.2 mg L-1), with the remainder of the wells along the cross section 
being at or below detection (< 0.1 mg L-1).  Along this cross section, DO was also 
determined and it was found that concentrations were less than 3 mg L-1 for all wells 
sampled, however, DO tended to be higher closer to the water table. 
 
The geochemistry of landfill leachate plumes extending into groundwater has been described 
widely in the literature (e.g., Christensen et al., 2001; Kjeldsen et al., 2002; Bjerg et al., 
2005; Lee et al., 2006).  The geochemical conditions observed at the Cambridge and 
Waterloo landfills were fairly consistent with leachate plumes emanating from engineered 
municipal landfills.  Namely, the presence of reduced species close to the landfill with 
decreasing concentrations moving downgradient, coupled with the introduction of more 
oxidized species further from the landfill.  The measured Eh also was observed to increase 
with distance at each landfill as the plume became more oxidizing.  The geochemistry at each 
site being typical of municipal waste sites allows for useful application of the results with 
regards to pharmaceuticals at other landfills with similar designs, waste streams, 






Pharmaceutical analyses were conducted along the cross section for caffeine, carbamazepine, 
sulfamethoxazole, gemfibrozil, naproxen and ibuprofen.  Concentrations of all drugs 
analysed were consistently below detection in laboratory and field Milli-Q blanks prepared 
using the same SPE process employed for the unknown samples (Table 3.2), with the 
possible exception of caffeine at concentrations less than 1 ng L-1, suggesting contamination 
within the instrument.  However, because the background peak for caffeine was present in all 
samples, including the calibration standards, no correction beyond those obtained through the 
application of the calibration regression equation was required.  Blank MeOH/Milli-Q 
samples spiked with internal standards for direct injection into the HPLC were below 
detection limits (Table 3.1) for all analytes, indicating the purity of the internal standards 
used (Table 3.2). 
 
Blind Milli-Q spiked samples prepared for quality control measures had high accuracies (91-
110 %) for all drugs across a range of concentrations (100 to 1000 ng L-1) (Table 3.2), 
indicating the accuracy of the calibration and analysis methods.  The accuracy is calculated 
by comparing the measured concentration in the quality control samples, to the expected 
concentration. 
 
3.3.2.2 Absolute Method Recovery 
The absolute method recovery of the internal standards was expressed by comparing the peak 
area (counts) of the internal standard in a control set of Milli-Q spiked samples (method 
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standards) passed through the SPE cartridges (n = 4) to MeOH/Milli-Q calibration standards 




(%)RecoveryMethodISAbsolute ×=  (3.1) 
In all unknown samples as well as the method standards, the internal standards were added 
prior to SPE, therefore the absolute method recovery is representative of the recovery of the 
SPE process, as well as the instrument detection capabilities.  The method standards were 
prepared to have final analyte concentrations of 0.2, 0.5, 1.0, and 5.0 μg L-1.  The effect of 
passing samples through a nylon filter is expected to be negligible for all of the drugs, based 
on a sorption study which indicated little to no loss of the PhACs from the aqueous phase 
when in continued contact with the nylon filters (Hebig, 2008).   
 
In addition, the absolute analyte recovery was calculated (Equation 2.2) for the method 
standards using the same method of comparing peak area in the method standards to peak 




(%)RecoveryMethodAnalyteAbsolute ×=  (3.2) 
The relative recovery of the analyte to internal standard was also calculated through a series 
of equations (Equations 3.3 and 3.4) to help indicate the relation between internal standard 
recovery and calculated analyte concentration.  The relative recovery ratio (Equation 3.3) 
was calculated for both the method standards and the calibration standards and then used to 











(%)RecoveryMethodRelative ×=  (3.4) 
The relative recovery is more reflective of the accuracy of the calibration and method, as it 
considers not only the internal standard recovery, but also the analyte recovery and therefore 
accounts for the isotope dilution technique that was used to calculate the final concentration 
of analytes in all samples. 
 
Table 2.4 and Figure 2.3 illustrate the three parameters calculated for the absolute method 
recovery of the method standards.  It is noted that ibuprofen (99 %), naproxen (86 %) and 
carbamazepine (86 %) had the best absolute recoveries of internal standards, however, the 
precision for all drugs ranged between 6 and 16 %.  Sulfamethoxazole had a very high 
internal standard absolute recovery (140 %), however, the absolute recovery of the 
sulfamethoxazole analyte was also high (151 %), which resulted in a satisfactory overall 
relative recovery of 107 % (Table 2.4, Figure 2.3), illustrating the importance and success of 
utilizing an appropriate internal standard for each individual analyte.  
 
For most of the pharmaceuticals analysed, the absolute recovery of the internal standard in 
the method standards was similar to the absolute recovery of the corresponding analyte, 
which resulted in a desirable relative recovery.  Carbamazepine, sulfamethoxazole, caffeine, 
and ibuprofen all had relative recoveries in the range of 99 to 107 %.  Naproxen and 
gemfibrozil had higher relative recoveries (119 % and 122 % respectively), which indicates 




3.3.2.3 Internal Standard Recovery 
Another recovery calculated took into consideration the matrix effects of each individual 
sample, combined with the absolute method recovery (Table 3.3).  In this recovery, the peak 
area of the internal standard in all unknown samples was compared to the peak area of the 
internal standard in the calibration standards that were analysed together within a single 




(%)RecoveryIS ×=  (3.5) 
For drugs analysed in positive mode, it was found that for carbamazepine, average sample 
recovery was low (52 and 60 % for Cambridge and Waterloo respectively) with high % RSD 
(36 % and 17 %).  Caffeine had a high sample recovery (128 % and 116 % respectively) and 
high % RSD (48 % and 25 %).  Sulfamethoxazole had better average recoveries (95 % and 
87 %), but still relatively high standard deviations.  The high standard deviations are not 
unexpected, given that across each field site, the geochemical properties and matrix effects 
varied from location to location.  Other studies investigating recoveries of pharmaceuticals in 
environmental samples found a wide range of recoveries and high standard deviations (Hao 
et al., 2006; Pedrouzo et al., 2007).  In this study, it was observed that for samples with high 
DOC (> 2 mg L-1), the recoveries were poor in comparison to the samples with low DOC (< 
2 mg L-1).  Having organic carbon present in the samples may create a competition with the 
target compounds for the available binding sites on the SPE adsorbents.  Alternatively, a 
previous study investigating surface waters did not find a correlation between DOC and 
recovery of analytes on SPE (Hao et al., 2006).  Rather, they attributed low recoveries to 
reduced extractability and/or ionization efficiency resulting from interactions between DOC 
and target analytes in analysis.  In particular, humic acids, a common component in landfill 
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leachates, were found to reduce signal suppression for some drugs (Hao et al., 2006).  For 
sulfonamide drugs, humic acids were found to have no affect (Hao et al., 2006), which is a 
possible reason why average sulfamethoxazole recoveries were generally more satisfactory 
than caffeine or carbamazepine. 
 
By dividing the sample locations at each field site into two separate populations defined by 
their DOC concentrations and focusing on the population with low DOC, in all cases the 
standard deviations were lowered, some quite dramatically, and average sample recoveries 
approached 100 % (with the exception of sulfamethoxazole) (Table 3.3).  For blind spiked 
Milli-Q samples, recoveries of internal standards for positive drugs were also not ideal, 
however, relative recoveries indicated that the low internal standards recovery was 
compensated for in the final calculation of the analyte concentration due to isotope dilution 
techniques (Table 3.3).  By selecting an internal standard that is similar to the analyte, the 
internal standards are expected to behave similarly to the analyte, and concentrations are 
accounted for by looking at the relative peak difference.  Additionally, the use of unique 
internal standards provides confidence when samples have non-detectable amounts of the 
analyte, but the internal standard is present. 
 
For the sample recovery of internal standards of the drugs analyzed in negative ESI mode, 
sample recoveries were closer to 100%, and standard deviations were lower for all drugs at 
each site (Table 3.3), indicating the method is perhaps more robust for these drugs.  Dividing 
samples into two populations based on high and low DOC concentrations as was performed 
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for the positive drugs had minimal effect.  It appears as though DOC had less affect on the 
recovery of the internal standards for the drugs analyzed in negative mode. 
 
3.3.2.4 Pharmaceutical Findings 
All samples collected were analyzed for the presence of pharmaceuticals with the exception 
of 77-89 (Waterloo Landfill) and CL 44B (Cambridge Landfill).  All samples for both the 
Cambridge and Waterloo Landfills were found to be below detection limits (Table 3.1) for 
caffeine, carbamazepine, sulfamethoxazole, naproxen, gemfibrozil and ibuprofen.  These 
negative findings were determined through the use of field, analytical and laboratory 
methods that have been successfully applied to a variety of other samples and sample 
matrices (Chapter 2; Siebert, 2007; Hebig, 2008), while employing high quality control 
measures.  A variety of extractions on duplicate samples were performed at varying times 
between when the samples were initially collected, to the final extraction after storing frozen 
samples for up to 10 months.  In all cases all PhACs were below detection, indicating good 
reproducibility between sample sets.  In addition, calibration standards were repeatedly run 
over a period of hours and days, with continued high accuracy.   
 
The lack of pharmaceuticals in groundwater goes not mean that organic contaminants are not 
present in the leachate plume, as vinyl chloride was detected during sampling events that 
occurred simultaneously to our sampling (Figures 3.3, 3.4 and 3.6) (Region of Waterloo, 




3.3.2.5 Pharmaceuticals in Municipal Waste Streams 
Previous studies conducted on surface water have found the presence of PhACs in the 
geographical area of interest in this study (Metcalfe et al., 2003; Hao et al., 2006; Lissemore 
et al., 2006; Lishman et al., 2006; Carrara et al., 2008).  Carbamazepine was detected in 
concentrations averaging 16.2 ng L-1 in a large river at eight different sampling locations, one 
of which was classified as receiving urban input.  In the same study, gemfibrozil (13.7 ng L-
1) and naproxen (41.7 ng L-1) were found in surface water receiving urban waste (Hao et al., 
2006; Lissemore et al., 2006).  Another study conducted in southern Ontario also found the 
presence of pharmaceutical compounds including naproxen, gemfibrozil, and ibuprofen in 
groundwater below septic tile beds in concentrations ranging below detection to as high as 
12,000 ng L-1 (ibuprofen) (Carrara et al., 2008), while a similar study found the six 
pharmaceuticals of interest downgradient of a tile bed in Southern Ontario (Chapter 2).  
Lishman et al. (2006) found the presence of multiple PhACs in Ontario municipal wastewater 
effluent, including gemfibrozil (mean 246 ng L-1), naproxen  (mean 452 ng L-1), ibuprofen 
(mean 384 ng L-1), while a similar study by Metcalfe et al. (2003) detected maximum 
concentrations of gemfibrozil (1.3 μg L-1), naproxen (33.9 μg L-1), ibuprofen (24.6 μg L-1) 
and carbamazepine (2.3 μg L-1) in sewage effluent across Canada.  Therefore, it is well 
documented that many of the PhACs evaluated in this study are present in the local 
environment and used by the general population being serviced by the landfills.  The only 
PhACs of interest without documentation of local environmental presence are caffeine and 
sulfamethoxazole.  Caffeine is widely consumed in beverages and is a commonly held non-
prescription medication, and sulfamethoxazole is an antibiotic that is typically used in high 
volumes (Khetan and Collins, 2007), therefore it is probable that these PhACs are utilized in 
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the geographical area of question.  Based on studies on pharmaceutical disposal habits 
(Bound and Voulvoulis, 2005; Bound et al., 2006; Slack et al., 2007b), it is likely that some 
of these PhACs are being deposited into landfills through either direct disposal of unused or 
expired medications, or though the disposal of human (i.e. diapers) or pet feces and urine. 
 
3.3.2.6 Municipal Waste Stream Characterization 
The Cambridge and Waterloo landfills are classified as municipal landfills, and receive a 
mixture of domestic, industrial, commercial, and inert waste in proportions that are fairly 
typical of municipal landfills throughout Canada (Environment Canada, 1996; Biersteker, 
2008).  Several of the studies that found PhACs in landfill groundwater plumes were 
conducted at sites that had not received traditional municipal waste compositions.  These 
sites received a relatively high amount of pharmaceutical waste from either the 
pharmaceutical industry or hospitals (Holm et al., 1995, Eckel et al., 1993).  The difference 
in waste streams is a possible explanation for the presence of pharmaceutical compounds in 
these previous studies, contrasting with the lack of pharmaceuticals in groundwater presented 
herein. 
 
3.3.2.7 Transport of Pharmaceuticals 
Pharmaceuticals not being detected in three separate leachate plumes could be due to such 
low quantities being deposited that drugs are not found in detectable amounts, and/or the 
geochemical and geological conditions at each site are supportive of rapid attenuation, 
preventing pharmaceuticals from entering the groundwater in measurable concentrations.  
Holm et al. (1995) found that drugs present in groundwater downgradient of the landfill 
 
  77
seemed to degrade most in the strongly anaerobic zones, such as in the methanogenic, 
sulfate-reducing and iron-reducing zones.  Because the landfills are strongly reducing, this 
could explain why the drugs were all below detection limits downgradient from the source, 
after passing through highly anaerobic areas.  
 
In addition to the oxidation-reduction conditions at the site, the site configuration and 
geology could contribute to the lack of PhACs in the groundwater below and downgradient 
of the landfills.  At each site studied, the leachate passes through an extensive vadose zone 
prior to entering the groundwater system.  Previous studies have found that pharmaceuticals 
show higher degradation and lower mobility under unsaturated conditions than during 
saturated transport (Scheytt et al., 2006; Chapter 2).  Many groundwater sites where elevated 
concentrations of pharmaceuticals have been identified, including two municipal landfills, 
have been characterized by shallow aquifer systems, with relatively thin vadose zones 
(Godfrey et al., 2007, Carrara et al., 2008, Ahel et al., 2004; Schwarzbauer et al., 2002).  In 
addition, Barnes et al. (2004) found pharmaceuticals in groundwater downgradient of an 
unlined municipal landfill in an alluvial plain, suggesting the importance of a properly 
engineered landfill.  Therefore, the conditions at the Cambridge and Waterloo landfills 
appear to be conducive to removal of any PhACs that may have been initially present in the 
leachate.  
 
The presence and transport of these pharmaceutical compounds in groundwater is dependant 
on the individual properties of the PhACs themselves.  Parameters such as the solubility, the 
acid-base dissociation constant (pKa), and the log Kow of each pharmaceutical affect their 
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transport.  It can be assumed that the majority of pharmaceuticals in the landfill are deposited 
in the solid phase, therefore, the concentrations of PhACs found in the aqueous phase would 
be dependant on the solubility of each compound, as well as the degree of contact with the 
solid phase with leachate or percolating rainwater.  The PhACs of interest with the highest 
solubilities are sulfamethoxazole and caffeine, with the remainder having moderately high 
solubilities (Table 2.1).  Therefore, all of these drugs have the potential to be dissolved if in 
contact with an aqueous phase. 
 
The pKa and the log Kow of each drug also plays an important role in their transport in 
groundwater.  The pKa denotes the pH at which each PhAC will dissociate (Figure 3.7).  
Given a measured pH range of 6.45 to 7.92 at the Cambridge landfill and 6.05 to 8.34 at the 
Waterloo landfill, all the acidic pharmaceuticals (ibuprofen, gemfibrozil, naproxen, 
sulfamethoxazole) would have been dissociated into their anionic forms in the groundwater.  
For all the pharmaceuticals studied, dissociation of the neutral parent compound would result 
in an anionic compound.  The charge of each PhAC has implications on the degree of 
sorption to solid matter.  It is difficult to predict the surface charge of the refuse within the 
waste pile, and how passage through the waste pile would affect sorption. 
 
Perhaps most important are the processes that would occur directly in the landfill during 
waste decomposition.  Several samples were collected at each field site from wells that were 
considered leachate wells, as they were within the limit of refuse.  Based on the results from 
these wells and from typical waste pile geochemistry (Christensen et al., 2001), predication 
can be made regarding the possibility of elimination within the waste pile.  A review of 
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literature found that pH in newer landfills ranges from 4.5 – 9 (Christensen et al., 2001), 
however, the pH at various locations within the waste pile will vary significantly depending 
on the age of the waste and the stage of decomposition.  During the early stages of waste 
decomposition, the pH of the leachate is low, and as the landfill stabilizes and 
methanogenesis becomes a significant process, the pH increases (Christensen et al., 2001).  
This fluctuation in pH likely has implications on the fate and transport of PhACs.  Initially 
when pH is low, not all compounds may be dissociated into their anionic forms, which could 
serve to hinder or enhance sorption affects.  It is difficult to predict how sorption may be 
affected, given the complex nature of the matrix in the landfill and the inability to predict 
surface properties of any potential sorption sites.  However, by examining parameters such as 
the pH dependant partitioning coefficient (log Dow) and the retardation coefficients (R) over 
the typical pH range, and assuming that the lower pH is representative of the early stage of 
decomposition, several trends emerge.  Log Dow was previously described in Chapter 2, and 








The Dow is important, particularly when assuming retardation coefficients.  Calculating 
retardation within the waste pile requires a variety of assumptions, including a waste pile 
bulk density, porosity, fraction of organic carbon (foc), and the assumption of saturated 
conditions.  The interpretation of retardation in this study is qualitative only, and as a result 
the final value of each retardation coefficient is not as important as the overall trends.  




R ρ+= 1  (3.7)
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An assumed bulk density (ρb) of 0.65 g cm3, and an effective porosity (n) of 0.4 were used, 
which are representative of typical landfill waste properties (Slack et al., 2007a), with an 
assumed foc of 25%.  The partitioning coefficient (Kd) was estimated from the following 
series of equations: 
663.0log679.0log += owoc KK  (3.8)
as developed by Gerstl (1990) and recently employed by Löffler et al. (2005).  However, in 
place of log Kow, the log Dow is used, allowing R to be calculated as a function of pH.  The Kd 
is then estimated based on the generalized expression.   
ococd fKK =  (3.9)
The retardation for all the acidic drugs increased with decreasing pH within the pH range 
from 4.5 to 9 (Figure 3.8), particularly for ibuprofen and gemfibrozil which were the PhACs 
with the highest log Kow.  As a result, the retardation of the acidic PhACs is likely more 
pronounced during the initial acid phase of a waste pile, which could contribute to the lack of 
detection in groundwater.  Considering the typically high organic fraction of waste, 
calculated retardation values were quite high, which could also contribute to attenuation of 
pharmaceutical compounds in landfill leachate plumes. 
 
Therefore, when considering the absence of PhACs in the groundwater plumes at the 
Cambridge and Waterloo landfills, there are a variety of factors that must be considered, 
including the composition of the waste stream, the geochemistry and geology of the site, as 
well as the chemical properties of each PhAC.  Further studies would be required to narrow 
the findings down to any one cause, and at this time it is believed that likely multiple factors 
are contributing to at least some degree to the elimination of PhACs in the leachate plumes. 
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3.3.2.8 Significance of Findings 
The significance of the negative findings when investigating the presence of PhACs at two 
municipal landfills are two-fold.  Firstly, prior to being able to definitively state that properly 
engineered, municipal landfills are not a consistent source of pharmaceuticals to 
groundwater, the need for additional studies has been identified.  Future studies should focus 
on less detailed studies across a larger number of landfills and a larger suite of drugs.  The 
second significant finding relates to public perception and government decision-making.  A 
recent study conducted by Doerr-MacEwan and Haight (2006) investigated the opinions of 
27 expert stakeholders in academia, industry and government on the presence of 
pharmaceuticals in the environment.  Of these stakeholders, 81 % believed that 
pharmaceuticals compounds are a concern to ecosystem health, mostly due to the bioactive 
nature of drugs.  As a result, it was generally believed (67 %) that it is somewhat or very 
important for government to take action to control the release of pharmaceuticals to the 
environment.  If the findings of the study by Doerr-MacEwan and Haight are applied to the 
local government in the vicinity of these landfills, it is important to consider that for the 
pharmaceuticals evaluated, landfills were not a source to groundwater contamination.  This 
finding has implications for government decisions related to where and how to implement 
control programs related to the release of pharmaceuticals to the environment to optimize 
both environmental controls and use of funds. 
 
3.4 Conclusions and Recommendations 
This study illustrates the possibility that ‘typical’ municipal landfills with modern and 
functioning control measures such as leachate collection systems and liners, coupled with a 
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typical municipal waste stream and characteristic plume geochemistry, may not be a 
consistent or definite contributor of pharmaceutical contamination to groundwater.  The need 
for future studies has been identified, expanding the study to include a variety of landfills and 
performing a preliminary investigation of leachate collection systems to help to determine if 
the landfills are a consistent source of PhACs, and searching for an expanded suite of 
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Carbamazepine  Positive    3/37 0.2/2.2 
 Cambridge Landfill  0.1 - 20 0.9996 96 - 104   
 Waterloo Landfill  0.1 - 20 0.9998 97 - 102   
                
Sulfamethoxazole  Positive    23/78 1.4/4.6 
 Cambridge Landfill  0.1 - 20 0.9997 96 - 103   
 Waterloo Landfill  0.1 - 20 0.9997 95 - 106   
                
Caffeine  Positive    0/20 0/1.2 
 Cambridge Landfill  0.1 - 20 0.9998 97 - 102   
 Waterloo Landfill  0.1 - 20 0.9996 97 - 106   
                
Gemfibrozil  Negative 0.1 - 20 0.9995 95 - 107 15/65 0.9/4 
 Cambridge Landfill       
 Waterloo Landfill       
                
Naproxen  Negative 0.1 - 20 0.9994 95 - 105 139/763 8/45 
 Cambridge Landfill       
 Waterloo Landfill       
                
Ibuprofen  Negative 0.1 - 60 0.9994 92 - 109 189/648 11/38 
 Cambridge Landfill       
  Waterloo Landfill             
Table 3.1 – Method Calibration.  Calibrations were performed using an 8 point linear range with a 1/x2 weighting factor.  The 
accuracy of the calibration standards illustrates how close the measured concentration of each standard was to the expected 
concentration.  The instrument method detection limit (MDL) and limit of quantification (LOQ) is representative of the capabilities of 





    
Accuracy of Blind 
Spikes (%) and 
%RSD 
Blanks (Lab and Field, 
and blanks spiked with 
IS) 
Carbamazepine Cambridge Landfill 98 +/- 4 < 0.2 ng L-1 
 Waterloo Landfill 98 +/- 2 < 0.2 ng L-1 
    
Sulfamethoxazole Cambridge Landfill 102 +/- 6 < 1.4 ng L-1 
 Waterloo Landfill 99 +/- 5 < 1.4 ng L-1 
    
Caffeine Cambridge Landfill 98 +/- 2 trace peaks in blanks 
 Waterloo Landfill 100 +/- 3 trace peaks in blanks 
    
Gemfibrozil   Cambridge Landfill 121 +/- 2 < 0.9 ng L-1 
 Waterloo Landfill 105 +/- 4 < 0.9 ng L-1 
    
Naproxen Cambridge Landfill 105 +/- 6 < 8 ng L-1 
 Waterloo Landfill 102 +/-6 < 8 ng L-1 
    
Ibuprofen Cambridge Landfill 94 +/- 15 < 11 ng L-1 
  Waterloo Landfill 102 +/-4 < 11 ng L-1 
  n = 3 (Cambridge)  
  n = 4 (Waterloo)  
Table 3.2 – Quality Assurance and Quality Control.  The accuracy of the blind spiked 
samples was measured by comparing the measured concentration to the expected 
concentration, and the residual standard deviation (%RSD) was also calculated.  Blank 
samples were continually processed throughout each analytical run.  Sample size (n) for each 






    
Sample Recovery of IS 
(%)   
High DOC Sample IS 
Recovery (%) 






Carbamazepine Cambridge Landfill 52 +/- 36 32 +/- 53 62 +/- 14 98 +/- 2 
 Waterloo Landfill 60 +/- 17 58 +/- 21 61 +/- 12 98 +/- 3 
      
Sulfamethoxazole Cambridge Landfill 95 +/- 24 107 +/- 24 88 +/- 21 104 +/- 6 
 Waterloo Landfill 87 +/- 12 93 +/- 11 82 +/- 10 103 +/- 10 
      
Caffeine Cambridge Landfill 128 +/- 48 183 +/- 44 99 +/- 16 99 +/- 2 
 Waterloo Landfill 116 +/- 25 133 +/- 26 101 +/- 8 101 +/- 2 
      
Gemfibrozil   Cambridge Landfill 96 +/- 12 94 +/- 13 99 +/- 11 116 +/- 4 
 Waterloo Landfill 99 +/- 9 97 +/- 10 100 +/- 8 102 +/- 4 
      
Naproxen Cambridge Landfill 92 +/- 18 87 +/- 20 97 +/- 17 105 +/- 10 
 Waterloo Landfill 98 +/- 13 99 +/- 14 98 +/- 13 102 +/- 5 
      
Ibuprofen Cambridge Landfill 94 +/- 12 92 +/- 12 93 +/- 11 99 +/- 4 
  Waterloo Landfill 101 +/- 10 101 +/- 12 101 +/- 8 106 +/- 13 
  n = 38 (Cambridge) n = 13 (Cambridge) n = 25 (Cambridge) n = 3 
  n = 31 (Waterloo) n = 15 (Waterloo) n = 16 (Waterloo)  
Table 3.3 – Recovery data.  The recovery of each internal standard (IS) and the per cent relative standard deviation (%RSD) is noted 
for all samples.  Recovery was determined by comparing the peak area of the internal standard in unknown samples, to the peak area 
of the internal standard in the calibration standards.  For each pharmaceutical, the recovery was separated into two population based 
on DOC concentration; high (> 2 mg L-1) and low (< 2 mg L-1).  In some cases, this DOC trend had an effect on the average and 
%RSD, where high DOC was associated with poor recovery. In addition, the relative recovery, which considers the ratio of the analyte 






Figure 3.1 – Detailed plan view at the Cambridge Landfill.  The location of all the sampling points are illustrated along cross sections 












Figure 3.3 – Contours of geochemical parameters along C-C’ at the Cambridge landfill.  One 
well in a perched aquifer was also sampled.  Results for vinyl chloride were obtained from 





Figure 3.4 – Contours of geochemical parameters along cross section D-D’ at the Cambridge.  
Vertical exaggeration of 7.  Black dots represents sampling points.  Results for vinyl chloride 




Figure 3. 5 – Detailed cross section for A-A’ at the Waterloo Landfill illustrating the location 





Figure 3.6 – Contours of geochemical parameters along cross section A-A’ at the Waterloo 
Landfill.  Results presented for vinyl chloride were obtained from the Region of Waterloo 





Figure 3.7 – pKa of each pharmaceutical of interest plotted on the pH scale.  The pH range of 
groundwater at the Cambridge and Waterloo Landfills (6.0 – 8.3) is noted. 
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Figure 3.8 – The pH dependant partitioning coefficient (Dow) was calculated for 
carbamazepine (CBZ), sulfamethoxazole (SMX), caffeine (CAF), ibuprofen (IBU), naproxen 
(NAP) and gemfibrozil (GEM) across the entire pH range.  Retardation (R) values across the 
entire pH range, as well as typical pH values in a waste pile, were also calculated.  A series 
of assumptions for waste were used in this calculation, including a bulk density of 0.65 g cm-
3, porosity of 0.4, organic carbon fraction of 25 %, and the assumption that the waste is fully 
saturated.  Due to the assumptions in this calculation, the retardation coefficients were 
interpreted qualitatively only to obtain a relative indication of the effects of pH on R, and an 
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APPENDIX A: SEPTIC SYSTEM DESIGN AND FUNCTION 
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The processes considered in the design and function of typical septic beds are summarized as 
follows (Willhem et al., 1994):  Conventional septic systems are designed to have three 
different zones, an anaerobic zone, an aerobic zone, and (sometimes) a second anaerobic 
zone.  The first anaerobic zone consists of the septic tank and a layer of accumulated organic 
matter below the distribution pipes, known as the biological mat.  Retention times in the 
septic tank are typically designed to be at least 24 hours.  Within the tank, physical treatment 
occurs through the settling of dense particles to create sludge, and floating particles are 
retained by hanging barriers, forming scum.  The tank remains mainly anaerobic despite the 
fact that it is vented due to the low diffusion coefficient of oxygen, which is further inhibited 
by the floating scum.  Therefore, any oxidation of reduced species, specifically organic 
matter, in the tank occurs anaerobically.  This biochemical treatment occurs through a variety 
of steps, the first of which involves microbially mediated hydrolyzation of large organic 
molecules into simpler molecules such as amino acids, sugars, and fatty acids.  The sugars 
and amino acids are then fermented, meaning organic carbon is oxidized and reduced to 
produce intermediate organic acids, acetate, and H2.  The fatty acids and intermediate organic 
acids then undergo anaerobic oxidation, accepting protons to form H2.  Finally, 
methanogenic bacteria in the tank use the acetate or CO2 and H2 to produce CH4 and CO2.  
The septic tank wastewater is discharged to the tile lines by gravity or pumps, where it 
infiltrates into the unsaturated zone. Directly below the tile lines, a biological mat typically 
forms. This mat strains out the suspended particles and organic matter, resulting in a build up 
of the mat over time, potentially slowing the rate of infiltration of wastewater into the 
aquifer.  Oxygen ingress into the mat is often limited during periods of high loadings.  The 
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processes that occur during this anaerobic stage tend to maintain a near-neutral pH, and the 
alkalinity of the waste water also remains fairly stable. 
 
Once the wastewater passes through the biological mat, it contacts increased concentrations 
of oxygen, which allows for aerobic degradation reactions to occur.  Because organic carbon 
(CH2O) and NH4 are thermodynamically unstable where O2 is available, they tend to readily 
oxidize.  In general, the limiting factor is the available O2, therefore it is important that the 
aerobic zone is sufficiently thick to promote oxidation reactions.  When NH4 is oxidized to 
NO3-, the pH and alkalinity are affected since 2H+ ions are released into solution for every 
one mol of NH4 consumed.  The oxidation of CH2O produces CO2, which decreases pH if it 
remains in solution, but only alters the alkalinity if it leads to CaCO3 dissolution.  Removal 
of organic carbon and nitrogen may also occur through direct reaction with the aquifer 
materials, however this removal is believed to occur to a lesser extent. 
 
After the aerobic degradation of NH4 and CH2O occurs, some systems may possess a second 
anaerobic zone known as the denitrification zone.  In this zone, the nitrate produced during 
oxidation of NH4 would be reduced to N2 gas, which is unavailable to most organisms.  This 
denitrification occurs by bacteria that require anoxic conditions to reduce NO3, therefore it 
would typically occur in saturated or near saturated sediments due to limited O2 diffusion.  
This process rarely occurs, however, because organic carbon is also needed to drive the 
reaction, but if the system is designed correctly, all the organic carbon should have been 
consumed during the aerobic stage when the NO3 itself was produced.  Therefore, typically 
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aquifers with a high fraction of organic carbon are the only environments where a 
denitrifying zone would develop. 
 
Therefore, the best treatment of the major wastewater constituents occurs if all three zones 
are achieved, since then not only is organic carbon being removed, but so is nitrate.  Potential 
problems that arise in the design and functioning capabilities of a septic bed include a 
fluctuating water table limiting the extent of the aerobic zone, a gradual loss of buffering 
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APPENDIX B: ANALYSIS OF FREEZING AND STORAGE OF SOLID PHASE 




In evaluating for the presence of various pharmaceuticals in the groundwater at this site, a 
variety of methodology tests were performed using the drug carbamazepine as a 
representative analyte.  One test investigated the effect of processing the sample immediately 
following collection, versus long-term storage through freezing, thawing, re-filtering and 
then analyzing.  An additional test that was conducted considered the impact of the age of the 
MeOH preserved solid phase extraction (SPE) eluate on the results obtained compared to 
results processed soon after SPE for the frozen samples. 
 
Effect of Freezing 
When evaluating the effect of freezing, thawing, and subsequently re-filtering with 0.45 μm 
nylon filters prior to sample preparation by SPE, results for samples frozen for approximately 
2 months (frozen samples) were compared to results for carbamazepine from a sample 
processed immediately after collection from the field and storage at 4°C until sample 
preparation by SPE (fresh samples).  No substantial visual difference between the 
carbamazepine plumes of the fresh and frozen sample sets was observed (Figure B.1), 
indicating that for the purpose of this analysis, either fresh or frozen samples are sufficient 
for purposes of data interpretation for carbamazepine.  In each preparation scenario 
calibrations were strong, having accuracies close to 100% (+/- 5%), with strong correlation 
coefficients (>0.999) (Table 2.2).  The percent difference between carbamazepine 
concentrations in fresh and frozen samples is plotted in Figure B.2.  The median of the 
percent difference between results was satisfactory at 14 %, while the average was 
significantly higher at 51 %.  The large difference in these statistics is the result of several 
samples which had substantially different carbamazepine concentrations, some of which 
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were run in duplicate or triplicate, thus having a greater influence on the average.  For the 
several samples run in triplicate that had a vast difference in concentrations, the frozen 
samples tended to have a much lower concentration than the fresh sample.  It is unclear why 
the results for several samples showed large differences, while the results for the majority of 
samples were relatively unaffected by the freezing and filtering process. 
 
Storage of SPE Eluate 
When investigating the drug carbamazepine, duplicate analyses of the frozen samples were 
conducted, allowing for comparison of results for samples processed soon after SPE, to up to 
6 months after.  SPE eluate was stored at 4°C for 6 months prior to being re-analyzed.  The 
contoured diagrams showing the influence of holding time on the analyses indicate negligible 
differences in the visual analyses at the plume scale (Figure B.3). 
 
A comparison of concentrations for carbamazepine obtained for the sample processed 
immediately after SPE relative to concentrations for the same samples re-analyzed 6 months 
later illustrates that the majority of the concentrations are similar (Table B.1).  The per cent 
difference between the two analyses illustrates this trend, with a mean per cent difference of 
16 % and a median percent difference of 14 %. 
 
In summary, a preliminary overview of carbamazepine analysis suggests that freezing of 
samples and storage of SPE eluate does not influence the visual interpretation of the plume 
concentration contours.  Further studies should be conducted for the other pharmaceuticals of 
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interest in this study (caffeine, sulfamethoxazole, naproxen, gemfibrozil, and ibuprofen) to 








(6 months) % Difference 
    
120 – 2.8 21 19 8 
120 – 2.8 16 19 -19 
120 – 3.4 520 460 12 
120 – 3.9 1259 1065 17 
120 - 4.6 876 747 16 
120 - 5.3 506 476 6 
    
121 - 2.6 318 291 9 
121 - 3.2 935 771 19 
121 - 3.8 1480 1280 14 
121 - 4.4 941 830 13 
121 - 5.0 994 835 17 
    
122 - 2.8 445 460 -3 
122 - 3.4 1200 930 25 
122 - 4.6 1510 960 45 
    
123 - 2.6 501 435 14 
123 - 3.2 1080 824 27 
123 - 3.8 2190 1510 37 
123 - 4.5 13 16 -21 
    
124 - 1.6 27 22 19 
124 - 2.1 184 173 6 
124 - 2.6 155 134 14 
124 - 3.1 119 103 14 
124 - 3.6 184 155 17 
    
136 - 1.9 41 40 4 
136 - 2.3 531 431 21 
136 - 2.7 502 465 8 
    
138 - 1.9 888 788 12 
138 - 2.3 2060 2050 0 
138 - 2.7 468 408 14 
138 - 3.1 606 564 7 
    
Tank 59 77 -26 
    
  Absolute Average 16 
  Absolute Median 14 




Table B.1 – Long Point groundwater concentrations for carbamazepine (CBZ) between 
samples analyzed immediately after solid phase extraction (SPE) (0 months) and the same 
sample rerun after storage of SPE eluate at 4°C for a period of 6 months (6 months).  The 
percent difference between these two analytical runs indicates results are similar, with an 
average percent difference of 16 %, and a median per cent difference of 14 %.  A positive 
percent difference indicates that eluate processed immediately after SPE had a higher 





Figure B.1 – Carbamazepine (CBZ) plume delineations are provided for two separate 
samples from Long Point groundwater.  The top plot is for a sample collected in the field, 
frozen, thawed, filtered, and then processed (frozen).  The lower plot is for a sample 
processed directly after collection, without being frozen or re-filtered (fresh).  While there is 
some variation in the plume, overall, the trends are the same, allowing for similar visual 





































Figure B.2 – Percent difference in carbamazepine concentrations is plotted for all samples 
analyzed between a sample processed after collected (fresh), and a sample frozen, thawed, 
filtered and then processed (frozen).  There are several bars with a very high per cent 
difference, many of which were run in duplicate or triplicate.  A positive percent difference 
indicates that the frozen sample had a higher concentration than the fresh sample.  The 
second plot illustrates the concentrations range for each sample, comparing the 






Figure B.3 – Plume delineations for carbamazepine (CBZ) for the same sample being 
analyzed immediately after SPE (0 months) and after storing solid phase extraction (SPE) 
eluate at 4°C for a period of 6 months (6 months).  There is no substantial difference between 



















  Cl NO3 NO3 SO4 PO4 NH3/NH4 
SAMPLE 
ID   mg L-1 mg L-1 as N mg L-1 mg L-1 as P mg L-1 as N mg L-1 
LP-124 1.6 7.60 3.17 0.72 39.8 0.008 < 0.1 
 2.1 5.00 8.41 1.90 14.4 <0.005 < 0.1 
 2.6 33.0 156.0 35.2 29.4 <0.005 < 0.1 
 2.6D 32.5 152.9 34.6 31.0 <0.005 < 0.1 
 3.1 54.1 250.1 56.5 40.1 <0.005 < 0.1 
 3.6 41.4 183.9 41.6 61.5 <0.005 < 0.1 
        
LP-136 1.9 45.0 270.8 61.2 29.6 1.07 0.1 
 2.3 2.34 0.61 0.14 5.69 <0.005 < 0.1 
 2.7 2.35 0.78 0.18 5.30 <0.005 < 0.1 
 2.7D 2.33 0.82 0.18 5.33 <0.005 < 0.1 
 3.1 19.9 70.6 15.9 14.0 <0.005 < 0.1 
        
LP-138 1.9 43.4 293.9 66.4 31.7 3.680 < 0.1 
 2.3 55.9 357.8 80.8 34.1 6.26 3.4 
 2.3D 55.6 357.5 80.8 31.1 6.36 3.4 
 2.7 56.1 277.3 62.7 32.8 0.014 < 0.1 
 3.1 51.1 232.7 52.6 48.8 <0.005 < 0.1 
        
LP-123 2.6 62.8 294.1 66.5 28.3 8.10 < 0.1 
 3.2 48.4 341.7 77.2 35.5 7.33 < 0.1 
 3.8 56.6 336.4 76.0 29.0 4.70 11.6 
 4.5 45.3 261.3 59.0 37.6 <0.005 < 0.1 
 4.5D 47.9 263.0 59.4 36.9 0.109 < 0.1 
        
LP 122 2.8 59.8 326.6 73.8 78.9 7.63 < 0.1 
 3.4 54.3 354.1 80.0 42.4 3.89 < 0.1 
 4.6 51.2 270.1 61.0 36.6 0.847 1.7 
 5.2 54.4 168.1 38.0 49.7 <0.005 < 0.1 
        
LP-120 2.8 59.5 363.9 82.2 24.1 2.58 < 0.1 
 2.9 61.2 369.6 83.5 24.7 2.62 < 0.1 
 3.4 53.1 347.5 78.5 29.3 4.64 4.2 
 3.9 52.4 253.7 57.3 39.2 0.977 0.8 
 4.6 52.7 162.7 36.8 63.5 <0.005 0.7 
 5.3 46.5 84.5 19.1 84.1 <0.005 0.2 
        
LP-121 2.6 58.9 434.9 98.3 75.3 5.79 0.8 
 3.2 59.1 326.5 73.8 39.9 3.94 3.0 
 3.8 53.4 348.4 78.7 39.0 1.28 2.4 
 4.4 52.2 271.3 61.3 30.3 0.126 1.9 
 5 49.4 186.3 42.1 43.1 <0.005 0.3 
        
LP Tank   64.2 -   31.5 16.03 148 
        
a - Data obtained from Will Robertson October 4, 2006.  All other reported data was obtained September 19, 2007 
Duplicates are denoted by "D"      





      
2006 Field Dataa 
  
  
  Mn NO3-N NO3- Cl 
SAMPLE ID mg L-1 mg L-1 mg L-1 mg L-1 
LP-
124 1.6 0.00 9 40 6 
 2.1 0.38 13 58 9 
 2.6 0.30 23 102 21 
 2.6D 0.29 - - - 
 3.1 0.11 33 146 31 
 3.6 0.15 18 80 30 
      
LP-
136 1.9 0.02 50 221 42 
 2.3 0.27 67 297 57 
 2.7 0.27 68 301 55 
 2.7D 0.27 - - - 
 3.1 0.38 57 252 32 
      
LP-
138 1.9 0.00 71 314 58 
 2.3 0.18 - - - 
 2.3D 0.18 72 319 59 
 2.7 0.12 69 305 51 
 3.1 0.60 62 274 53 
      
LP-
123 2.6 0.01 84 372 55 
 3.2 0.03 68 301 59 
 3.8 - 61 270 56 
 4.5 0.15 24 106 36 
 4.5D 0.15 - - - 
      
LP 
122 2.8 0.00    
 3.4 -    
 4.6 0.64    
 5.2 0.17    
      
LP-
120 2.8 0.36    
 2.9 0.29    
 3.4 0.57    
 3.9 0.19    
 4.6 1.61    
 5.3 0.19    
      
LP-
121 2.6 -    
 3.2 0.64    
 3.8 0.23    
 4.4 -    
 5 0.3    
      
LP 
Tank   -       
      
a - Data obtained from Will Robertson October 4, 2006.  All other reported data was obtained September 19, 
2007 
Duplicates are denoted by "D"    

















Well ID Temperature pH Corrected Eh F Cl 
  °C   mV mg L-1 mg L-1 
CL 10A ] 7.79 440 < 0.08 8.3 
CL 51B 15.5 7.63 390 < 0.08 9.1 
CL 51A 15 7.3 120 < 0.08 4.6 
CL 52B 13 6.55 110 < 0.08 224.0 
CL 53A 9.8 7.16 220 0.63 3.6 
CL 25A 10.2 6.72 90 < 0.08 152.1 
CL 25B 10.8 7.74 450 < 0.08 77.5 
CL 25C 8.2 7.28 470 < 0.08 5.1 
CL 53C 9.1 n/a n/a < 0.08 4.8 
CL 53B 10 7.92 460 < 0.08 2.18 
CL 52A 10 6.82 40 < 0.08 98.4 
CL 10  12 6.77 220 < 0.08 77.3 
CL 9B 18 6.45 20 < 0.08 34.6 
B102 13 6.64 190 < 0.08 507.8 
CL 47B 11.5 7.49 160 < 0.08 - 
CL 47D    < 0.08 - 
CL 47C 11 6.85 500 < 0.08 66.07 
CL 47A 11 7.15 280 < 0.08 - 
CL 64B 11 6.58 200 < 0.08 400.2 
CL 64C 13.5 6.6 160 < 0.08 69.1 
A101 11 6.79 250 < 0.08 116.4 
A102    < 0.08 116.6 
CL 63B 10.5 7.34 390 < 0.08 84.6 
CL 63C 10.1 7 420 < 0.08 34.2 
CL 55C 11.4 7.1 510 < 0.08 652.3 
CL 55B 10.8 7.34 190 < 0.08 58.9 
CL 55D    < 0.08 651.0 
CL 29 9.9 7.35 470 < 0.08 75.8 
CL 9  11.3 7.58 140 0.28 4.69 
CL 24B 11 7.22 450 < 0.08 8.22 
CL 70 35.8 7.36 n/a < 0.08  
CL 68 22.8 6.48 n/a < 0.08  
CL 69 25.2 6.86 n/a < 0.08  
CL 44B 13.2 6.47 n/a < 0.08   
CL 55 D is duplicate of CL 55 C 
n/a or '-' denotes sample not analysed for 
parameter 
A102 is duplicate of A101    





Well ID NO3 NO3 as N SO4 PO4 as P DOC NH3/NH4 as N 
  mg L-1 mg L-1 mg L-1 mg L-1 mg L-1 mg L-1 
CL 10A < 0.4 < 0.09 24.1 0.008 < 1 < 0.1 
CL 51B < 0.4 < 0.09 29.7 < 0.005 1.7 0.3 
CL 51A < 0.4 < 0.09 22.1 0.006 < 1 < 0.1 
CL 52B < 0.4 < 0.09 < 0.2 0.015 22.6 1.4 
CL 53A < 0.4 < 0.09 83.1 < 0.005 1.7 < 0.1 
CL 25A < 0.4 < 0.09 26.5 < 0.005 3.1 0.2 
CL 25B 1.53 0.35 58.7 < 0.005 < 1 < 0.1 
CL 25C < 0.4 < 0.09 23.8 < 0.005 1.4 < 0.1 
CL 53C < 0.4 < 0.09 28.4 < 0.005 1.3 < 0.1 
CL 53B < 0.4 < 0.09 14.9 < 0.005 < 1 < 0.1 
CL 52A < 0.4 < 0.09 11.0 < 0.005 8.4 0.5 
CL 10  < 0.4 < 0.09 < 0.2 < 0.005 4.3 < 0.1 
CL 9B < 0.4 < 0.09 12.2 < 0.005 5.6 < 0.1 
B102 < 0.4 < 0.09 < 0.2 < 0.005 65.4 46.6 
CL 47B < 0.4 < 0.09 417.0 0.005 < 1 0.2 
CL 47D < 0.4 < 0.09 443.0 < 0.005 < 1 0.2 
CL 47C < 0.4 < 0.09 56.7 < 0.005 2.6 < 0.1 
CL 47A < 0.4 < 0.09 792.6 < 0.005 <1 0.2 
CL 64B < 0.4 < 0.09 < 0.2 0.011 32.5 11.6 
CL 64C < 0.4 < 0.09 < 0.2 0.080 18.2 1 
A101 < 0.4 < 0.09 31.0 < 0.005 2.4 < 0.1 
A102 < 0.4 < 0.09 31.5 < 0.005 2.8 < 0.1 
CL 63B < 0.4 < 0.09 23.9 < 0.005 < 1 < 0.1 
CL 63C < 0.4 < 0.09 21.4 < 0.005 < 1 < 0.1 
CL 55C < 0.4 < 0.09 39.5 < 0.005 < 1 < 0.1 
CL 55B < 0.4 < 0.09 27.5 < 0.005 < 1 < 0.1 
CL 55D < 0.4 < 0.09 53.4 < 0.005 < 1 0.1 
CL 29 < 0.4 < 0.09 35.3 < 0.005 < 1 < 0.1 
CL 9  < 0.4 < 0.09 24.2 0.005 < 1 < 0.1 
CL 24B < 0.4 < 0.09 24.9 < 0.005 < 1 < 0.1 
CL 70 < 0.4 < 0.09 n/a 1.387 881 1550 
CL 68 < 0.4 < 0.09 n/a 0.005 6.5 6.8 
CL 69 < 0.4 < 0.09 n/a 1.722 103 1.8 
CL 44B < 0.4 < 0.09 n/a 0.005 11.9 19.5 
 CL 55 D is duplicate of CL 55 C n/a or '-' denotes sample not analysed for 
 A102 is duplicate of A101  parameter   





        Alkalinity (with 1.6N H2SO4)  






Volume  Digits Alkalinity 
  mg L-1 mg L-1 mg L-1 (mL) (to pH 4.5) (mg L-1 Total CaCO3) 
CL 10A 2.3 1.7 2.0 125 271 217 
CL 51B 0.7 0.7 0.7 24.8 50 202 
CL 51A 0.5 0.4 0.5 21.6 59 273 
CL 52B 18.3 19.8 19.0 23.2 244 1052 
CL 53A < 0.2 < 0.2 < 0.2 24.4 75 307 
CL 25A 10.0 9.0 9.5 24 187 779 
CL 25B < 0.2 < 0.2 < 0.2 22.8 83 364 
CL 25C < 0.2 < 0.2 < 0.2 24.3 74 305 
CL 53C 1.5 1.5 1.5 23.4 87 372 
CL 53B < 0.2 < 0.2 < 0.2 24 48 200 
CL 52A 9.3 8.1 8.7 24 156 650 
CL 10  18.6 15.4 17.0 24.1 199 826 
CL 9B 10.0 11.0 10.5 24.2 294 1215 
B102 8.5 8.5 8.5 24.2 393 1624 
CL 47B < 0.2 < 0.2 < 0.2 22.6 52 230 
CL 47D < 0.2 < 0.2 < 0.2 22.6 52 230 
CL 47C 0.4 0.4 0.4 21.4 122 570 
CL 47A < 0.2 < 0.2 < 0.2 23.5 84 357 
CL 64B 9.0 8.9 9.0 23.6 277 1174 
CL 64C 4.3 4.2 4.3 24.2 208 860 
A101 1.7 1.6 1.7 22 116 527 
A102 1.6 1.7 1.7 22 116 527 
CL 63B < 0.2 < 0.2 < 0.2 22.4 77 344 
CL 63C < 0.2 < 0.2 < 0.2 22 54 245 
CL 55C < 0.2 < 0.2 < 0.2 24.7 119 482 
CL 55B 2.6 2.8 2.7 22.5 83 369 
CL 55D < 0.2 < 0.2 < 0.2    
CL 29 1.2 1.2 1.2 24.3 87 358 
CL 9  0.7 0.7 0.7 24.6 63 256 
CL 24B < 0.2 < 0.2 < 0.2 24.8 90 363 
CL 70 6.1 6.7 6.4 n/a n/a n/a 
CL 68 8.4 8.1 8.2 n/a n/a n/a 
CL 69 15.9 17.1 16.5 n/a n/a n/a 
CL 44B 12.2 11.9 12.0 n/a n/a n/a 
 CL 55 D is duplicate of CL 55 C n/a or '-' denotes sample not analysed for parameter 
 A102 is duplicate of A101     


















Sample ID pH 
Corrected 
Eh Cl NO3 NO3 as N 
    mV mg L-1 mg L-1 mg L-2 
298 - 99 6.83 170 62.2 < 0.4 < 0.09 
WW 9 8.34 240 2.7 < 0.4 < 0.09 
 8 - 83 8.09 40 26.8 < 0.4 < 0.09 
334 - 03 6.5 - 7 n/a 164.4 < 0.4 < 0.09 
316A - 01 6.5 270 4.5 < 0.4 < 0.09 
324B - 02 6.41 330 18.2 < 0.4 < 0.09 
 7 - 83 6.97 120 58.3 < 0.4 < 0.09 
320 - 02 6.25 140 11.6 < 0.4 < 0.09 
77 - 89 7.07 120 14.4 < 0.4 < 0.09 
318 - 01 6.64 220 15.2 < 0.4 < 0.09 
318 - 08 n/a n/a 15.2 < 0.4 < 0.09 
164 - 92 7.37 120 30.2 < 0.4 < 0.09 
84 - B 7.48 140 5.7 < 0.4 < 0.09 
296A - 99 6.67 170 13. 4 < 0.4 < 0.09 
308A - 01 7.42 100 11.0 < 0.4 < 0.09 
308B - 01 6.05 180 7.8 < 0.4 < 0.09 
309A - 01 7.59 210 3.4 < 0.4 < 0.09 
309B - 01 7.18 190 12.0 < 0.4 < 0.09 
310A - 01 7.48 100 3.7 < 0.4 < 0.09 
312A - 01 7.46 380 n/a n/a n/a 
312C - 01   5.1 0.62 0.14 
312B - 01 7.28 370 4.3 0.51 0.12 
315A - 01 7.53 150 14.5 < 0.4 < 0.09 
317 - 01 6.95 150 49.3 < 0.4 < 0.09 
321 - 03 7.31 140 9.6 < 0.4 < 0.09 
      
312 A-01 and 312C-01 are duplicates    





Sample ID SO4 PO4 as P DOC 
NH3/NH4 
as N DO 
  mg L-1 mg L-1 mg L-1 mg L-1 mg L-1 
298 - 99 50.0 0.008 12.5 < 0.1 2.5 
WW 9 6.3 0.0140 < 1 0.2 0.2 
 8 - 83 51.1 0.005 2.5 < 0.1 0.8 
334 - 03 < 0.2 0.185 116.0 24.0 1.0 
316A - 01 25.4 0.015 11.5 < 0.1 0.9 
324B - 02 23.7 0.014 2.8 < 0.1 1 
 7 - 83 < 0.2 0.017 55.3 0.1 0.2 
320 - 02 56.1 0.019 1.1 < 0.1 0.4 
77 - 89 39.0 0.018 1.3 < 0.1 0.3 
318 - 01 49.7 0.015 4 0.1 2 
318 - 08 49.6 0.016 3.7 0.1 n/a 
164 - 92 47.4 0.017 < 1 < 0.1 0.8 
84 - B 75.1 0.027 < 1 < 0.1 0.9 
296A - 99 33.3 0.008 < 3 < 0.1 0.8 
308A - 01 63.9 0.008 < 1 < 0.1 0.4 
308B - 01 66.3 0.006 < 1 < 0.1 1 
309A - 01 62.3 0.005 < 1 < 0.1 0.9 
309B - 01 54.0 < 0.005 < 1 < 0.1 0.6 
310A - 01 52.9 0.008 < 1 < 0.1 0.3 
312A - 01 n/a < 0.005 < 1 < 0.1 0.6 
312C - 01 60.4 0.007 < 1 < 0.1 n/a 
312B - 01 67.7 0.008 < 1 < 0.1 0.9 
315A - 01 24.1 0.007 < 1 < 0.1 3 
317 - 01 26.1 0.019 4.4 1.9 3 
321 - 03 55.6 0.009 < 1 < 0.1 0.4 
      
 312 A-01 and 312C-01 are duplicates   












Average: Volume  Digits Alkalinity  
  mg L-1 mg L-1 mg L-1 mL (to pH 4.5) 
mg L-1 as 
CaCO3 
298 - 99 3.8 4.6 4.2 24 125 521 
WW 9 < 0.2 0.2 0.1 24.4 34 139 
 8 - 83 < 0.2 n/a < 0.2 21.2 55 259 
334 - 03 4.9 4.8 4.8 24.8 234 943.5 
316A - 01 0.8 1.6 1.2 23.9 236 987 
324B - 02 7.9 6.9 7.4 22.4 179 799 
 7 - 83 n/a 8.5 8.5 24 145 604 
320 - 02 1.3 1.2 1.2 23.4 75 321 
77 - 89 3.2 2.7 3.0 24 99 413 
318 - 01 17.8 21.1 19.5 24.6 98 398 
318 - 08 20.9 24.4 22.6 n/a n/a n/a 
164 - 92 0.6 0.5 0.5 24 71 296 
84 - B < 0.2 < 0.2 < 0.2 24.2 77 318 
296A - 99 7.0 7.5 7.3 24.6 187 760 
308A - 01 < 0.2 < 0.2 < 0.2 24.7 65 263 
308B - 01 n/a n/a n/a 23.5 103 438 
309A - 01 < 0.2 < 0.2 < 0.2 22.6 67 297 
309B - 01 2.4 2.2 2.3 24.7 100 405 
310A - 01 < 0.2 < 0.2 < 0.2 24.2 63 260 
312A - 01 0.6 0.6 0.6 24.8 75 302 
312C - 01 n/a 0.8 0.8 n/a n/a n/a 
312B - 01 0.5 0.5 0.5 23.5 83 353 
315A - 01 0.7 0.7 0.7 24.9 72 289 
317 - 01 1.1 0.9 1.0 22.3 77 345 
321 - 03 1.0 1.0 1.0 22.5 80 356 
       
 312 A-01 and 312C-01 are duplicates    
 318-08 is a duplicate of 318-01    
 
 
